{
  "name" : "dacemirror.sci-hub.se_journal-article_589728d9beb9dca3e7e7b5f803974706_ge2019.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "Recent Advances on Black Phosphorus for Biomedicine and Biosensing",
    "authors" : [ "Xiaoxiao Ge", "Zhonghong Xia", "Shaojun Guo" ],
    "emails" : [ "guosj@pku.edu.cn" ],
    "sections" : [ {
      "heading" : null,
      "text" : "REVIEW www.afm-journal.de\n© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1900318 (1 of 32)\nBlack phosphorus nanostructures (nano-BPs) include BP nanosheets, BP quantum dots, and BP nanoparticles. Since first being discovered in 2014, nano-BP has become one of the most popular nanomaterials. Nano-BP has many unique properties, such as excellent surface activity, tunable bandgap, high carrier mobility, moderate on/off ratio, excellent biocompatibility, good biodegradation, etc., all of which make nano-BP particularly attractive in biomedicine and biosensing. This review article comprehensively summarizes recent advances in synthesis, functionalization, biomedicine, and biosensing applications of nano-BP. Different methods are first introduced, such as mechanical cleavage, liquid-phase ultrasonic exfoliation, electrochemical exfoliation, solvothermal treatment, and acoustic-microfluidic stripping, for making the nano-BP. Then two strategies are emphasized to enhance ambient stability of nano-BP, namely physical encapsulation and chemical modification. Next, how to develop nano-BP as advanced imaging agents, nanocarriers, and nanomedicine for bioimaging (fluorescence imaging, thermal imaging, and photoacoustic imaging) and disease treatment (phototherapy and photo/chemical/immune synergistic therapy) is demonstrated. The biosensing applications on nano-BP is introduced, including electrochemical biosensor, fluorescence biosensor, chemiluminescence biosensor, electrogenerated chemiluminescence biosensor, and colorimetric biosensor. Finally, the current challenges and future perspectives on nano-BP in bioapplications are discussed.\nRecent Advances on Black Phosphorus for Biomedicine and Biosensing\nXiaoxiao Ge, Zhonghong Xia, and Shaojun Guo*\nDOI: 10.1002/adfm.201900318\nDr. X. Ge, Dr. Z. Xia, Prof. S. Guo Department of Materials Science and Engineering, College of Engineering Peking University Beijing 100871, P. R. China E-mail: guosj@pku.edu.cn Prof. S. Guo BIC-ESAT College of Engineering Peking University Beijing 100871, P. R. China\nThe ORCID identification number(s) for the author(s) of this article can be found under https://doi.org/10.1002/adfm.201900318."
    }, {
      "heading" : "1. Introduction",
      "text" : "The rapid development of advanced functional nanomaterials provides the fertile soil for exploring high-performance biomedical and biosensing platforms. Particularly, the emergence of 2D nanomaterials has inspired the strong interests of researchers from different disciplines.[1] 2D nanomaterials have many advantages over bulk counterparts due to their ultrathin\nBiomedicine\nstructure, large surface-to-volume ratio, excellent thermal and electronic conductivity, sensitive photoresponsivity and robust mechanical flexibility.[2] Moreover, the use of various synthesis and modification approaches renders 2D nanomaterials have the controllable sizes and rich features that show great attraction in bioimaging,[3] disease theranostic,[4] and biosensing fields.[5] Since graphene was first exfoliated from graphite in 2004,[6] the reports on graphene and its derivatives show an explosive growth.[7] Especially in the biological fields, graphene-based biosensing platform[8,9] and graphene nanocomposites-based drug delivery system[10–13] are two of the most studied systems. Following the success of graphene, many graphene analogues were extensively explored, mainly including transition metal dichalcogenides (TMDs),[14] MXene nanosheets,[15] hexagonal boron nitride (h-BN) nanosheets[16] and graphitic carbon nitride (g-C3N4).[17] Apart from the similar structure with graphene, graphene analogues display diversified elemental compositions and more distinct features,[18] providing more candidates for the design of biosen-\nsors and drug delivery platforms.[19] For example, single-layer g-C3N4 quantum dots have extraordinary two-photo adsorption, and achieve high-resolution two-photon fluorescence imaging toward cellular nuclei.[20,21] The h-BN nanosheets, due to the preferential endocytosis by cells, appear as a desirable alternative in drug delivery system.[22] However, some problems on the biological applications of graphene and graphene analogues are still existed in the current progress. For instance, the zero bandgap of graphene limits its application in biodevices, and the long-term retention of TMDs containing heavy metal ions for the biomedical application is a huge threat to organism.\nLayered black phosphorus (BP), a rookie of 2D nanomaterials family, has aroused great interest from the enormous research fields, such as energy storage and conversion,[23,24] optoelectronic device,[25] biomedicine and biosensing.[26] Phosphorus has three main allotropes, including red phosphorus (RP), white phosphorus (WP), and BP. Among them, BP has the highest density, and is the most stable one. Bridgman first synthesized bulk BP through high-temperature and high-pressure transformation of white phosphorus in 1914,[27] but the related fundamental research and application did not achieve the considerable breakthrough until the discovery of layered BP in 2014. Every P atom is\nAdv. Funct. Mater. 2019, 29, 1900318\n1900318 (2 of 32) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\ncovalently bonded with three neighboring P atom by sp3 hybridization to form a puckered honeycomb structure. The adjacent two BP layers are weakly stacked on each other via the van der Waals interaction. Using the external forces, monolayer or fewlayer BP nanostructures are exfoliated from bulk BP. Layered BP holds an essentially direct and layer-dependent bandgap from 0.3 eV for bulk size to 2.0 eV for monolayer, thence exhibiting a broad absorption range from the visible to mid-infrared region for broadening its potential photonics and optoelectronics applications.[28] Additionally, layered BP has a sufficiently high carrier mobility of ≈10 000 cm2 V−1 s−1 and a moderate on/off ratio of 10 000 to 100 000.[29] These unique surface properties and optoelectronics properties make layered BP be particularly appealing in many important research areas, including field effect transistor (FET) sensing, bioassay and biomedicine.\nDespite the fascinating benefits, layered BP still suffers from a great obstacle. It is that when exposure to ambient air or aqueous solution, layered BP can undergo severe degradation to generate nontoxic PxOy, gradually losing its original performance. Such ambient instability of layered BP greatly impedes its related optoelectronics and sensing applications. Some necessary passivation strategies must be adopted to protect layered BP and maintain its normal functions. Nevertheless, in the biomedical area, this defect may be a good gift. Regardless of the ultralarge loading surface from its puckered honeycomb structure for therapeutic agents, biomolecules and imaging agents,[30] layered BP exposure to physiological environment does not bring any risks of long-time toxicity and poor excretion from organism because of its ease-to-degradation. Compared with other 2D nanomaterials, layered BP is a highly competitive nanoagent with outstanding biodegradability and biocompatibility.\nTo date, numerous reports have been demonstrated to show the significant breakthrough of layered BP in various aspects. Walia’s group and Abate’s group made detailed discussions and summary for the environmental instability of layered BP and corresponding protection strategies.[31,32] The multifunctional applications on layered BP were of particular concerned, but most of the reviews mainly focused on energy, catalysis, sensing, and optoelectronics.[33] Only several reviews systematically summarized the progress of layered BP in biomedicine.[34] The comprehensive review on layered BP toward biological application is rarely reported.\nIn this review article, we will give an exhaustive introduction of layered BP in biological application, mainly including biomedicine and biosensing. Herein, the involved layered BP mainly includes three nanostructures, 2D BP nanosheets, 0D BP quantum dots (BPQDs) and BP nanoparticles (or nanodots), all of which are collectively called nano-BP. The development of BP nanomaterials was generally introduced by a timeline (Figure 1). First, the advantages of 2D nanomaterials and unique features of nano-BP are briefly discussed. The subsequent contents are mainly concentrated on the synthetic methods and functionalization approaches of nanoBP. As for the biomedical application of nano-BP, the bioimaging and disease treatment are the main focus of interest. Nano-BP-based bioimaging will be summarized from three aspects: fluorescence imaging, thermal imaging, and photoacoustic imaging. Disease treatment includes phototherapy and synergistic therapy. The former mainly discusses photothermal therapy and photodynamic therapy while the later highlights the combination of phototherapy and drug therapy, gene therapy as well as immunotherapy. The detail on nanoBP biosensor is far less abundant than that of biomedical application. According to the distinct detection methods, six nano-BP-based biosensors will be demonstrated: electrochemical biosensor, FET biosensor, fluorescence biosensor, chemiluminescence biosensor, electrogenerated chemiluminescence biosensor, and colorimetric biosensor. Finally, the remaining challenges and future perspectives of nano-BP in biomedical and biosensing will be provided.\nXiaoxiao Ge received her Ph.D. degree in organic chemistry at Central China Normal University in 2017. Currently, she is working as a postdoctoral fellow with Prof. Shaojun Guo in the College of Engineering at Peking University. Her research interests mainly focus on the functionalized nanomaterials for biomedical and biosensing application.\nZhonghong Xia is currently a postdoctoral fellow under the supervision of Prof. Shaojun Guo at Peking University. He received his Ph.D. degree in engineering at the College of Engineering, Peking University in 2018. His research interests include the design, synthesis, and characterization of nanostructured materials applied to various electrocatalytic reactions.\nShaojun Guo is a professor in the Department of Materials Science and Engineering, College of Engineering, Peking University, and a fellow of the Royal Society of Chemistry. He is renowned for his leadership in nano/ sub-nano/atomic materials for catalysis, energy, and biomedical applications. Guo holds a B.S. degree in mate-\nrials chemistry (2005) from Jilin University and a Ph.D. degree in analytical chemistry (2010) from Changchun Institute of Applied Chemistry, Chinese Academy of Sciences.\nAdv. Funct. Mater. 2019, 29, 1900318"
    }, {
      "heading" : "2. Nano-BP Synthesis",
      "text" : "Layered nanomaterials are usually exfoliated from bulk crystals.[35] Compared with bulk materials, monolayer or fewlayer nanomaterials possess the enhanced surface area, excellent physiochemical activity and optoelectronic property. The exfoliation from bulk crystal to monolayer or few-layer nanosheets has been widely applied for preparing almost all the 2D nanomaterials, graphene, MoS2, MXene nanosheets, etc.[36] Bulk BP, similar to graphite, is the stacking of layered BP nanosheets via the weak van der Waals force. The destruction of the external driving forces to the weak van der Waals interaction between the stack layers greatly contributes to the exfoliation\nof nano-BP from the bulk counterparts. Mechanical exfoliation and liquid phase ultrasonic exfoliation are the two most popular approaches, and some other methods were also involved, electrochemical exfoliation and solvothermal treatment, for instance. Table 1 summarizes the advantages and limitations of different exfoliation methods."
    }, {
      "heading" : "2.1. Mechanical Exfoliation",
      "text" : "Mechanical exfoliation, also called scotch-tape delamination, mainly utilizes the larger binding energy between the substrate and layered materials than van der Waals forces in\nFigure 1. A timeline of experimental advances toward nano-BP development in biomedicine and biosensing fields.\n1900318 (4 of 32) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\ninterlayer to exfoliate ultrathin nanosheets from bulk crystals. It has been widely used for the synthesis of graphene and graphene analogues. Mechanical exfoliation was the first reported one for making layered BP.[37] However, with the commonly used SiO2/Si or Si substrates underneath, the obtained BP nanosheets exhibited obviously inhomogeneous size and extremely low yield. Metal-assisted mechanical exfoliation was put forward as a viable solution toward high production of few-layer BP (FLBP).[38] Figure 2a shows the schematic illustration of the proposed method. A gold or silver (Au/Ag) layer with about 10 nm was first deposited onto SiO2/Si wafer as the cleavage substrate, and the next operation was the same as the normal mechanical exfoliation. Finally, the metal layer was etched with the help of Au etching TFA solution, and FLBP was achieved (route A). Route B showed the transfer process of FLBP to other substrate. Due to the higher binding energy between metal (Au/Ag) layer and layered BP nanosheets, FLBP was easily peeled off from bulk BP. By controlling the wrinkled surface of bulk BP pasted on the tape and the quality of the metal layer, the FLBP with the larger lateral size of more than 50 µm could be obtained (Figure 2b). Moreover, the large-size FLBP yield was much higher than that of the normal scotchtap microcleavage (Figure 2c). The generation of monolayer BP nanosheets was then achieved via combining Ar+ plasma thinning process with mechanical exfoliation (Figure 2d–g).[39]\nThe polydimethylsiloxane (PDMS)-based intermediate viscoelastic substrate was another alternative to obtain the atomically thin BP flakes with high yield.[40] And the resulted thin BP flakes on PDMS substrate can be transferred to another substrate by putting PDMS substrate slightly contacting with the new substrate, and peeling it off slowly. Photoluminescence (PL) measurements demonstrate that the thinner BP flakes exhibit the more obvious PL peak, strongly supporting their tunable optical bandgap and great potential in photoelectronic field. Though regarded as the most stable allotrope of phosphorus, BP still faces the challenge of being easily degraded against ambient environment. Bulk BP crystal is usually stored in glove box for the future use. During the process of mechanical exfoliation, the obtained BP nanosheets inevitably were exposed to air, thereby making it difficult to store for a long time."
    }, {
      "heading" : "2.2. Liquid-Phase Ultrasonic Exfoliation",
      "text" : "Liquid-phase ultrasonic exfoliation is the most popular method for preparing nano-BP.[41] Its principle is mainly based on the balanced surface energy between exfoliation solvent and layer material.[42] For nano-BP preparation, N-methyl-2-pyrrolidone (NMP) is the most commonly used solvent. Layer BP crystal was exposed in NMP, followed by ultrasonic treatment. Ultrasonic waves produced large amounts of cavitation bubbles that collapse into high-energy jets, destructing the weak van der Waals interaction between the adjacent sheets of bulk BP to induce the formation of monolayer or few-layer BP. The participation of solvent not only improved the dispersibility of BP nanosheets, but also protected BP nanosheets from being air degraded, effectively avoiding the problem of instability from mechanical exfoliation. Brent et al. first reported on liquid-phase ultrasonic\nexfoliation of few-layer BP, and found that prolonging ultrasonic time promoted the generation of the thinner BP nanosheets.[43] Shortly afterward, an ameliorated liquid-phase ultrasonic exfoliation method with saturated NaOH-NMP solution as solvent was developed for the cleavage of BP nanosheets (Figure 3a).[44] The obtained BP nanosheets exhibited much higher concentration and more excellent stability in both NMP and water. Correspondingly, the NaOH-NMP-exfoliated BP showed a more negative zeta potential (−30.9 mV) than that of NMP-exfoliated one (−19.7 mV), providing a supplementary explanation for the excellent stability of the former. TEM results reveal that the regulation of the centrifugal speed was favorable in controlling the size of the exfoliated BP nanosheets (Figure 3b,c). In the Raman spectra of monolayer BP nanosheets, three typical Raman peaks at 362.5, 439.3, and 467.6 cm−1 correspond to the A1g, B2g, and A2g modes, respectively. With increasing the layer thickness of BP nanosheets, all the three modes appeared a certain degree of red shift. As expected, BP nanosheets centrifuged at 18 000 rpm exhibited larger blue shift than those centrifuged at 12 000 rpm, indicating that the BP nanosheets after centrifugation at 18 000 rpm have thinner layer (Figure 3d). Overall, the basic-NMP solvent in liquid-phase ultrasonic exfoliation system greatly promoted the generation of thinner BP nanosheets. Bath ultrasonication is the commonly used ultrasonic treatment, but it does not guarantee an absolute free-water and free-oxygen environment, allowing the existence of potential reaction between BP and oxidizing agents. To better address the aforementioned issue, a novel sealed-tip ultrasonication system was adopted (Figure 3e).[45] The tip ultrasonication possesses much higher powers that can greatly improve the efficiency of liquid phase stripping toward BP nanosheets. In addition, the solvents with the higher boiling point and surface tension were prone to produce the higher concentration of BP nanosheets (Figure 3f,g). NMP was determined as the optimal exfoliation solvent for the stable BP nanosheets.\nApart from BP nanosheets, BPQDs with ultrasmall size can be obtained by liquid phase ultrasonic exfoliation.[46] Different from the layered BP nanosheets, some minor alterations were performed specifically in the experiment process. For example, NMP solution containing bulk BP was first placed in a mortar and mechanically ground for 20 min, followed by ultrasonic treatment in ice bath environment for another 3 h. BPQDs were achieved by centrifugation at 7000 rpm for 20 min, with the average diameter of 4.9 ± 1.6 nm and the average thickness of 1.9 ± 0.9 nm. The integration of bath sonication and probe sonication proved to be efficient for the BPQDs preparation.[47] Probe sonication was more reproducible than mechanical grinding. BP solution after probe sonication treatment was more convenient to perform the following bath sonication, efficiently avoiding the external transfer progress. Phytic acid is a polar molecule with the rich hydroxyl groups and phosphate carboxyl groups, exhibiting excellent solubility in both water and organic solvents. The mixed solvents of phytic acid/ DMF and phytic acid/NMP were of particularly suitable for the liquid-phase ultrasonic exfoliation of bulk BP into nanoBP with much higher yield and better quality.[48,49] Except for organic solvent, water has also been used as exfoliation solution for the synthesis of nano-BP. However, the as-exfoliated nanoBP still faces the challenge of low yield.[50]\nAdv. Funct. Mater. 2019, 29, 1900318\n1900318 (5 of 32) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimAdv. Funct. Mater. 2019, 29, 1900318\nFigure 2. a) Schematic illustration of meta-assisted mechanical exfoliation for FLBP. b) The left is FLBPs exfoliated using the normal scotch-tape microcleavage, and the right is FLBP exfoliated using Au-assisted method, and c) the total area of FLBP on 10 different samples. Modified with permission.[38] Copyright 2018, the Royal Society of Chemistry. Optical image of multilayered BP d) before and e) after Ar+ plasma thinning. f) Reflection image of the plasma-treated flake in (b). Scale bars in (d)–(f) are 5 µm. g) TEM image of few-layer BP with an inset showing the SAED pattern (scale bar: 500 nm). Reproduced with permission.[39] Copyright 2018, Springer Nature.\n1900318 (6 of 32) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimAdv. Funct. Mater. 2019, 29, 1900318\nFigure 3. a) Schematic illustration of the NaOH-NMP-exfoliated BP nanosheets. TEM image of b) BP nanosheets by centrifugation at 12 000 rpm and c) BP nanosheets by centrifugation at 18 000 rpm. d) Raman spectra of BP nanosheets in water after centrifugation at 12 000 rpm and 18 000 rpm. Reproduced with permission.[44] Copyright 2015, Wiley-VCH. e) The structure of the proposed sealed-tip ultrasonication setup. f) BP concentration for various exfoliation solvents with different boiling points before and after 5000 rpm centrifugation and g) with different surface tensions after 5000 rpm centrifugation. Reproduced with permission.[45] Copyright 2015, American Chemical Society.\n1900318 (7 of 32) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim"
    }, {
      "heading" : "2.3. Other Exfoliation Methods",
      "text" : "Though mechanical exfoliation and liquid phase ultrasonic exfoliation have been recognized as the two popular ones for the nano-BP preparation, some other methods are still applicable, such as electrochemical exfoliation,[51,133] solvothermal treatment[52,53] and so on. In the electrochemical exfoliation, bulk BP and Na2SO4 were used as working electrode and the ionic solution, respectively.[54] By applying a positive bias on the working electrode, water molecules were oxidized to generate •OH and •O radicals that inserted between adjacent layers of bulk BP, weakening the layer-tolayer van der Waals interaction of bulk BP crystal. When the free radical was oxidized to generate oxygen, BP nanosheets were successfully peeled off from the bulk BP. Electrochemical exfoliation of nano-BP is simple and fast, as well as without any additive catalyst, but the thickness of nanoBP obtained does not exhibit sufficient uniformity. If the electrochemically stripped nano-BP was then treated with ultrasonication, it is expected to achieve nano-BP with uniform thickness. Solvothermal treatment was a convenient method to obtain the BPQDs.[55] As displayed in Figure 4a, bulk BP was subjected to grind treatment and subsequently solvothermal treatment with saturated NaOH-NMP solution as solvent, achieving BPQDs with ultrasmall size of about 2.1 ± 0.9 nm and good dispersion (Figure 4b–e). Furthermore, BPQDs exhibited blue-green fluorescence under the irradiation of UV light of 365 nm, providing great potential for developing novel bioimaging platform and fluorescent sensing technique.[53] In addition, the milling crushing of bulk BP was reported to attain few layered thin BP nanoparticles with the yield of over 60 wt%.[56] Another interesting acoustic-microfluidic (AM) platform successfully achieved highly efficient and continuous production of few-layer BP nanosheets and BPQDs.[57] The designed AM system not only promoted the efficient mixing and mass transfer, but also enhanced the dispersion of nano-BP by the acoustic waves, generated from the continuous-flow of the confined microchannel space, significantly improving the preparation efficiency of nano-BP. The yield of BP nanosheets reached 45 wt% in 6 min, and prolonging AM process to 18 min directly led to the generation of BPQDs. Moreover, the obtained nano-BP by AM exfoliation was proved to be stable for up to 8 months."
    }, {
      "heading" : "3. Nano-BP Functionalization",
      "text" : "The unique geometric and electronic structure of nano-BP endows them many appealing surface properties and photoelectric properties that show great promising in biomedical and biosensing applications.[58,59] Within every layer of BP with honeycomb structure, each phosphorus atom forms three covalent bonds with the adjacent phosphorus atoms, leaving one pair of electrons exposed outside. The remaining lone pair of electrons is prone to react with oxygen at ambient condition for generating PxOy that is responsible for the degradation of BP. Therefore, the isolation of the lone pair of electrons from oxygen and water is to protect the ambient stability of nano-BP. Currently, physical encapsulation and chemical modifications are the two commonly used ones.\nAdv. Funct. Mater. 2019, 29, 1900318\n1900318 (8 of 32) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim"
    }, {
      "heading" : "3.1. Physical Encapsulation",
      "text" : "Physical encapsulation usually employs the nanomaterials or polymers with excellent stability as barriers to block the toughing of water and oxygen toward nano-BP.[60] Physical encapsulation not only efficiently improves the chemical stability of nano-BP against ambient environment, but also reserves the pristine structure and property of nano-BP.\nNanomaterial modification is generally suitable to construct highly stable nano-BP-based electronic devices. For instance, atomic-layer deposition (ALD) of Al2O3 on the surface of BP nanosheets greatly improved the stability of BP-based FET (BPFET) devices for at least eight months.[61] The SiO2-passivated BP flakes-based FET still retained the on/off current of over 600 and mobility of 470.4 cm2 V−1 s−1 even after exposure to ambient condition for one week, just a little lower than the initial levels while the BPFET without SiO2 passivation exhibited a rapid drop of the on/off current and mobility.[62] Mechanically exfoliated BP nanosheets encapsulated with graphene/ ultrathin BN nanocomposites were treated by annealing, forming a dense BN/graphene/BP interface.[63] The typical Raman peaks of BP nanosheets before and after annealing treatment did not display any observed change, indicating that the encapsulation of BN/graphene effectively reserved the pristine property of BP.\nPolymer encapsulation has been commonly applied to improve the stability of nano-BP in biological environment. PEG is the most popular one, and its encapsulation on the surface of nano-BP appropriately prevents the direct contact with water, further enhancing the physiological stability and biocompatibility of nano-BP.[97,108] PEGylated BP nanoparticles can be synthesized directly by one-pot solventless high-energy mechanical milling technique. The obtained PEGylated BP nanoparticles displayed good dispersion in distilled water.[91] The freshly prepared BPQDs possess good water solubility, but they are easily aggregated when exposed to salt solution that greatly limits their application in biomedical field. By coating PEG-NH2 on the surface of BPQDs, the zeta potential of BPQDs was obviously changed from −26.0 to −13.2 mV, simultaneously improving the stability of BPQDs in phosphate buffered saline (PBS) and cell-culture media (DMEM).[47] When co-incubated with cell, PEG modified BPQDs exhibited excellent thermal stability. Some other polymers were also utilized to enhance the ambient stability of nano-BP. Based on the reasonable electrostatic interaction and hydrophobic force between the butyl chains and BP, poly-l-lysine (pLL) modified BP nanosheets (pLL/BP) displayed improved stability and good biocompatibility.[129] Besides, the pLL/BP hybrid still preserved the original honeycomb structure and electron transfer of BP flakes, thus receiving much appreciable attention in electrochemical biosensing field.[115,128] The hydrophobic poly (lactic-co-glycolic acid) (PLGA) as nanocages could encapsulate BPQDs inside to form BPQDs/PLGA nanospheres, efficiently protecting BPQDs from being exposed in ambient medium.[64] As displayed in Figure 5, with the exposure time of samples solution to air increasing, the color and the corresponding absorption spectra of BPQDs exhibited a fast drop while those of BPQDs/PLGA nanospheres did not show any obvious change. Raman characterization demonstrated that due to the degradation of BPQDs under ambient condition,\nthe three typical peaks of BPQDs emerged obvious blue shift. Benefiting from the protection of PLGA toward BPQDs, the BPQDs/PLGA nanospheres still exhibited excellent photothermal performance when exposure to air for 8 d. Nonetheless, benefiting from the remarkable hydrophobic property of PLGA, the prepared BPQDs/PLGA powder can be stored for at least 3 months, fully confirming the great potential of BPQDs/ PLGA as a stable photothermal agent for photothermal therapy of diseases. In addition, BP nanosheets have also been encapsulated with anthraquinone and assembly organic monolayers to achieve the enhanced biostability.[65]"
    }, {
      "heading" : "3.2. Chemical Modification",
      "text" : "Chemical modification is based on the chemical bond between the passivated molecules and nano-BP. Apart from the achievement of highly stable nano-BP, chemical modification is of particularly beneficial in manipulating the optical and electronic properties of nano-BP.[66] Inspired by the formation of PC bond between BP and graphite via high-energy mechanical milling, the aryl diazonium chemistry was reported as an acceptable covalent modification strategy toward nano-BP.[67] When exposed to ambient environment, BP flakes with aryl diazonium functionalization exhibited more prominent morphological stability than bare BP flakes. As expected, aryl diazonium functionalized BP nanoflakes-based FET device showed considerably improved on/off current ratio and hole mobility. With the help of the aryl diazonium chemistry, Nile Blue (NB) dyes were covalently bound to the surface of BP nanosheets, not only improving the stability of BP nanosheets against the physiological environment, but also endowing them with NIR fluorescent imaging.[79]\nSurface coordination is another approach to retard nano-BP from being degraded in ambient environment, which primarily depends on the occupation of transition metals to the lone pair of electrons of phosphorus and the subsequent blocking toward the reaction between the lone pair of electrons and oxygen.[68] BP nanosheets with the coordination of titanium sulfonate ligand (designated as TiL4, L referring to the sulfonic ester group) formed TiL4@BP complexes (Figure 6a).[69] Besides the coordination interaction between BP nanosheets and titanium, the electrophilic effect of sulfonic ester further accelerated the formation of TiL4@BP. The optical absorbance of both bare BP and TiL4@BP after exposure in water for different time was monitored (Figure 6b,c). With increasing the dispersion time in water, the absorption intensity of bare BP showed a rapid decrease while for TiL4@BP, the absorbance still remained the fairly original value even when the dispersion time was up to 72 h, meaning the excellent protection of TiL4 to BP nanosheets. Optical images clearly demonstrated that when exposure to the environment with a relative humidity of 95% at room temperature for different time duration, the droplets on the surface of bare BP become larger and denser while the surface topography of TiL4@BP remained the initial level (Figure 6d,e). Chemical modification of TiL4 greatly enhanced the stability of BP nanosheets against ambient air. The photothermal performance of bare BP and TiL4@BP was also explored, showing that at 72 h postexposure to water, the photothermal effect of TiL4@BP\nAdv. Funct. Mater. 2019, 29, 1900318\n1900318 (9 of 32) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nsolution retained the initial state under 808 nm laser irradiation for 10 min whereas bare BP presented a sharp decrease owning to the lack of TiL4 protection. Further biocompatibility of bare BP and TiL4@BP was subsequently explored by in vitro and in vivo experiments.[70] TiL4 modification helped BP nanosheets escape from the engulfment by macrophage, efficiently reducing the cytotoxicity and proinflammation.\nIn addition, Te-doping approach has also been proved to slow down the ambient degradation of nano-BP.[71] With RP and tellurium as precursors, Te-doping BP crystal was first synthesized by high temperature and high pressure. Consequently, Te-doping BP nanosheets were achieved by the conventionally mechanical exfoliation. The 31P magic angle spinning (MAS) nuclear magnetic resonance (NMR) and atomic force microscope (AFM) results reveal that Te-doping BP nanosheets show much better ambient stability than undoping BP. The metal cation-π interaction supported by density functional theory (DFT) calculation demonstrates a novel strategy for the functionalization of nano-BP.[72] In each layer of BP, the left lone pair of electrons of every phosphorus atom were uniformly distributed on the two sides and interact with each other to form a conjugated π bond. By cation–π interaction, metal ions were captured onto the surface of BP nanosheets.[72] Taking Ag+ as an example, the high-resolution X-ray photoelectron spectroscopy of Ag-BP complexes after exposure to air for 3 d did not experience any observed oxidative behavior compared with the\nAdv. Funct. Mater. 2019, 29, 1900318\nFigure 5. Stability assessment of BPQDs and BPQDs/PLGA under aqueous solution. The absorption spectra of a) BPQDs and b) BPQDs/PLGA NSs with the same amount of BPQDs (20 ppm) after storing in water for different periods of time (Insets in (b) and (c): the Tyndall effect and the variation of the absorption ratios (A/A0) at 808 nm). Raman scattering spectra acquired from c) BPQDs and d) BPQDs/PLGA, respectively. Photothermal heating curves of e) BPQDs and f) BPQDs/PLGA, respectively, after storing in water for different periods of time and being irradiated with the 808 nm laser (1 W cm−2) for 10 min. Reproduced with permission.[64] Copyright 2016, Nature.\n1900318 (10 of 32) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nrobust PxOy peak of bare BP at 134.0 eV. It was known that the phosphorus atoms at the edge were more susceptible to be oxidized by oxygen than that in the intermediate portion.[73] The nonselective all-round modification was the focus of the previously reported strategy on BP functionalization.[74] Undoubtedly, it may bring some interference to the pristine structure and property of BP to a certain degree. In light of the aforementioned flaws, the hydrophobic C60 molecules-based edge-selective functionalization strategy was arguably an ideal method.[75] According to the published report, C60 molecules edge-selectively functionalized graphene has been successfully attained by solid-state mechanochemical route of ball-milling.[76] With bulk BP and C60 powder as precursors, BP-C60 hybrid was synthesized in one step by the same method. UV–vis absorption spectra verified that the edge-selective modification by C60 could well stabilize BP nanosheets against ambient air. The BP-C60 hybrid presented an obviously enhanced photoelectric conversion property and photocatalytic activity for the applications of photoelectrochemical cell and photocatalytic Rhodamine B (RhB) dye degradation. The selectively passivating strategy of C60 modification shed a new light for solving the ambient stability of BP and broadening their optoelectronic applications."
    }, {
      "heading" : "4. Biomedical Application of Nano-BP",
      "text" : "A wide variety of synthetic methods and functional strategies enable nano-BP with controllable size and excellent surface activity as well as distinctive physicochemical properties, making them particularly be popular in biomedical applications.\nAdv. Funct. Mater. 2019, 29, 1900318\nFigure 6. a) The structure of TiL4 and surface coordination of TiL4 to BP. b) Absorption spectra of the bare BP and c) TiL4@BP dispersed in water after exposure to air for 0, 6, 24, 48, and 72 h. Optical images of d) bare BP and e) TiL4@BP sheets on Si/SiO2 and exposed to the humid air at room temperature for 0 (left), 12 (middle), and 24 h (right). Reproduced with permission.[69] Copyright 2016, Wiley-VCH.\n1900318 (11 of 32) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nTable 2 systematically summarizes the biomedical applications of nano-BP and their related synthetic components."
    }, {
      "heading" : "4.1. Bioimaging",
      "text" : ""
    }, {
      "heading" : "4.1.1. Fluorescence Imaging",
      "text" : "The layer thickness-dependent bandgap of nano-BP endows BP with superior optoelectronic property. Photoluminescence (PL) spectra demonstrate that the thinner BP flakes show the more obvious PL peak.[40] BP nanosheets with two to five layers have pronounced layer-dependent PL effect, and the strongest PL intensity was achieved in bilayer BP nanosheets.[77] The PL spectra of BP nanodots, and the relevant application on bioimaging were explored.[78] By the ultrasonication-assisted solution method, high-yield BP nanodots with an average diameter of ≈10 nm and height of ≈8.7 nm were achieved. BP nanodots exhibited an excitation wavelength-dependent PL behavior and the maximum quantum yield was ≈7.2%. When the excitation wavelengths were 220, 234, 280, and 370 nm, the blue and green fluorescences were significantly captured. Through the coincubation with Hela cells, BP nanodots displayed unobserved cytotoxicity, and strong FL imaging. Nile Blue diazonium (NB-D) tetrafluoroborate salt with NIR light adsorption covalently modified onto BP nanosheets, forming NB@BPs with environmental stability and NIR fluorescence imaging.[79] Both in vitro and in vivo experiments were carried out. Considerable red fluorescence signals were observed only in MCF-7 cancer cells treated with NB@BPs and 570 nm light excitation (Figure 7a–f). At 1 h postinjection of NB@BPs in MCF7 breast tumor-bearing Balb/c nude mice, the fluorescence signal was distributed disorderly in the body of mice whereas the fluorescence signals were apparently observed from the tumor and some organs after 24 h postinjection (Figure 7g). NB@BPs could be considered as an excellent FL agent for noninvasive monitoring tumor. PEGylated BPQDs acted as nanocarriers for loading organic fluorescent dyes, RhB. The formed fluorescence probes, RhB/PEG-BPQDs, were distinctly located in the cytoplasm for FL imaging of Hep\nG2 cells and 4T1 cells.[80] Fluorescence cyanine7-loading BP nanoparticles achieved the desirable in vivo NIR FL imaging toward 4T1 tumor-bearing mice.[81]"
    }, {
      "heading" : "4.1.2. Thermal Imaging",
      "text" : "Due to its excellent photothermal conversion efficiency, the temperature and thermal picture of nano-BP under NIR irradiation can be recorded in real-time manner with thermal imaging devices. Thus, nano-BP that enables reliable in vivo thermal imaging can be regarded as an ideal thermal agent. BPQDs and BP nanoparticles have already been applied to achieve in vivo thermal imaging for tumor-bearing mice after 808 nm laser irradiation.[82,83] The nanocomposites of BP nanosheets/ cellulose (namely cellulose/BPNSs) showed the reliable results in in vivo NIR thermal imaging of tumor-bearing mice.[84] As shown in Figure 7h,i, in the tumor-bearing mice treated with cellulose/BPNSs, the temperature at tumor site exhibited sharp evaluation from 33.0 to 64.1 °C.\nPolymer encapsulation has already been widely used to improve the stability of BP nanosheets against ambient environment. Furthermore, the polymers with special NIR light adsorption may unexpectedly enhance the photothermal effect of BP nanosheets. For example, BP@polydopamine (PDA) nanocomposites demonstrated the merit of PDA in the improved photothermal performance.[85] It turned out that a noticeable rise of 27.1 °C in temperature arose for BP@PDA, higher than that of bare BP (the temperature change of 24.1 °C). The tumor-beared mice were treated with the injection BP@PDA, followed by laser irradiation. The tumor site exhibited a significantly increased temperature change and a quite clear thermal imaging."
    }, {
      "heading" : "4.1.3. Photoacoustic Imaging",
      "text" : "Very recently, photoacoustic (PA) imaging was developed as an in vivo biophotonic diagnostic approach. It is superior to\nAdv. Funct. Mater. 2019, 29, 1900318\n1900318 (12 of 32) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimAdv. Funct. Mater. 2019, 29, 1900318\nFigure 7. In vitro and in vivo fluorescence bioimaging. a–c) White light images, and d–f) corresponding fluorescence images of MCF7 cells incubated with PBS, bare BPs, and NB@BPs, respectively. g) Fluorescence images of the MCF7 breast tumor-bearing nude mice treated with the NB@BPs via the tail vein at the postinjection of different time points. Reproduced with permission.[79] Copyright 2017, American Chemical Society. The tumorbearing mice were intratumorally injected with blank hydrogel or cellulose/BPNSs (380 ppm), with NIR irradiation. h) The temperature changes after NIR irradiation of the hydrogel and cellulose/BPNS groups. i) Time-dependent temperature changes during irradiation. Adapted with permission.[84] Copyright 2018, Wiley-VCH.\n1900318 (13 of 32) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\ntraditional optical imaging techniques in terms of high image sensitivity, high spatial resolution with depth up to several centimeters and depth-resolved 3D imaging.[86] Nanomaterials with excellent photothermal performance have been chosen as novel exogenous contrast agent, in which both PA signal and PA sensitivity will be largely improved.[87,88] Nano-BP has also garnered considerable interest from researchers in exploring their application in in vivo PA imaging.[89] TiL4@BPQDs with the enhanced ambient stability was proved to be an excellent PA contrast agent.[90] As displayed in Figure 8a,b, the PA\nAdv. Funct. Mater. 2019, 29, 1900318\nFigure 8. a) PA images of TiL4@BPQDs at different excitation wavelengths. b) PA signal and corresponding absorption intensities of TiL4@ BPQDs at different excitation wavelengths. c) PA images of the TiL4@BPQDs and AuNRs for different optical densities at 680 nm. d) Corresponding signal intensities of the TiL4@BPQDs and AuNRs for different optical densities at 680 nm. Reproduced with permission.[90] Copyright 2017, Wiley-VCH. e) In vitro photoacoustic images of PEGylated BP nanoparticles solutions (first row), and in vivo photoacoustic images of liver, kidney, and tumor obtained at different time intervals after intravenous injection of PEGylated BP nanoparticles, in comparison with the corresponding precontrast images. Adapted with permission.[91] Copyright 2016, Elsevier.\n1900318 (14 of 32) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nintensity of TiL4@BPQDs was negatively dependent on the laser wavelength ranging from 680 to 808 nm in which the strongest PA signal was obtained at 680 nm. The PA signal of TiL4@BPQDs only with concentration of 22.0 ppm was nearly 7.29 times higher than that of Au NRs with 79.8 ppm concentration, fully demonstrating the remarkable PA performance of TiL4@BPQDs (Figure 8c,d). Further in vitro and in vivo experiments were performed to evaluate the PA sensitivity of TiL4@BPQDs. When exposed to the cells with only 0.63 million, TiL4@BPQDs exhibited remarkable PA imaging ability for ultrasmall cancer lesions. For MCF7 tumor-bearing Balb/c nude mice, the PA signal was captured at 4 h postinjection of TiL4@BPQD. Afterward, the PA signal reduced gradually and returned to the preinjection level after 48 h. Both in vitro and in vivo experiments demonstrated the excellent PA performance of TiL4@BPQDs and their favorable prospect in clinical application. Benefiting from the exceptional photothermal conversion efficiency, PEGylated BP nanoparticles exhibited the desirable PA signal, the intensity of which was positively correlated with the concentration of PEGylated BP nanoparticles (the upper section in Figure 8e).[91] The preinjection PA signal was considerably weak. Upon the injection of PEGylated BP nanoparticles into tumor-beared mice, the PA signal in the liver, kidney and tumor regions was significantly enhanced. However, after 24 injections, PA signal in tumor site still remained salient while the PA signal in liver and kidney disappeared due to the effective metabolism, indicative of the specific accumulation of PEGylated BP nanoparticles in tumor (Figure 8e). PEGylated BP nanoparticles are promising as highly sensitive PA contrast agent for clinical cancer diagnosis."
    }, {
      "heading" : "4.2. Phototherapy",
      "text" : "Phototherapy mainly includes photothermal therapy (PTT) and photodynamic therapy (PDT).[92] PTT utilizes photoabsorbing agents to perform hyperthermia-induced cell death while PDT adopts the photosensitizers to generate cytotoxic reactive oxygen species (ROS).[93,94] Nano-BP has been at the center of tremendous research on their application to PTT as well as PDT owing to their unique optoelectronic properties.[95–97]"
    }, {
      "heading" : "4.2.1. Photothermal Therapy",
      "text" : "Nano-BP has a wide absorption across the entire visible light region, exhibiting outstanding NIR photothermal performance.[98–100] The photothermal conversion efficiency of BPQDs was reported to reach 28.4%, and the extinction coefficient at 808 nm was 14.8 L g−1 cm−1.[47] There is no discernible downward trend with regard to the photothermal behavior of BPQDs even after five on-off laser cycles, strongly demonstrating their remarkable photostability and great potential as photothermal agents. Under 808 nm laser irradiation for 10 min, nearly all the C6 (glioma cells) and MCF7 (breast cancer cells) cells incubated with 50 ppm of BPQDs for 4 h were killed (Figure 9a,b), significantly indicating the obvious photothermal destruction of BPQDs. BP nanosheets with different sizes have also been studied to evaluate their distinct cytocompatibility and capability of\nphotothermal ablation toward cancer cells.[101] It was shown that BP nanosheets with larger size possessed better photothermal ablation of cancer cells. Besides, the biostability of BP nanosheets is particularly critical for full exertion of photothermal effects. NB@BPs nanocomposites were injected into the tumor-bearing mice, followed by 808 nm laser irradiation.[79] It should be noted that the tumor temperature in the mice treated with NB@BPs was elevated by 23.5 °C whereas that of the mice treated with bare BPs was increased by only 11.5 °C due to rapid degradation of bare BPs during blood circulation (Figure 9c). Moreover, the tumor in the mice with the injection of NB@BPs gradually reduced in size, and finally vanished within 16 d (Figure 9d). By contrast, bare BP nanosheets gradually lost their inherent PTT ability of tumor because of the lack of NB protection.\nAs demonstrated before, the coating of foreign substance not only endows nano-BP FL imaging, but also unexpectedly enhances the PTT effect of nano-BP. Chlorine6 (Ce6) was a commercial photosensitizer with NIR light absorption. Ce6 immobilization on PEGylated BP nanosheets (BP@PEG/Ce6) enabled the NIR FL imaging in living animals, and achieved the increase of the photothermal conversion efficiency of PEGylated BP nanosheets from 28.7 to 43.6%.[97] Under 660 nm laser irradiation with 0.65 W cm−2 for 10 min, BP@PEG/Ce6 exhibited more pronounced photothermal effect than BP@PEG. The phenomenon from in vitro and in vivo experiments successfully proved the enhanced PTT effect toward cancer cells. BP@PEG/ Ce6-based strategy provided great potential for developing highly efficient and multifunctional PTT platforms. The direct integration of single-layer tannic acid (TA)-Mn2+ chelate networks on BP nanosheets (BPNS@TA-Mn2+) successfully achieved MRI/PA dual-modal imaging-guided PTT toward tumor.[102]"
    }, {
      "heading" : "4.2.2. Photodynamic Therapy",
      "text" : "PDT is another important strategy for cancer treatment that works in conjunction with PTT. The photodynamic effect of BP nanosheets with unique electronic structure was systematically investigated.[50] The probe molecule of 1,3-diphenylisobenzofuran (DPBF) and the electron spin resonance (ESR) spectra have been historically applied to characterize the 1O2 generation, respectively. 2,6,6-Tetramethylpiperidine (TEMP) usually acted as 1O2 trapping agent that could react with 1O2 to form 2,2,6,6-tetramethylpiperidine-N-oxyl (TEMPO), generating a typically 1:1:1 triplet signal in ESR spectra. As shown in Figure 10a,b, BP nanosheets show a decrease of DPBF absorption at around 410 nm with time, and simultaneously displayed the special 1:1:1 triplet signal of TEMPO. The capability of 1O2 generation induced by BP nanosheets substantiated their excellent photodynamic effect. Moreover, upon the introduction of sodium azide (NaN3, a scavenger of 1O2), no characteristic signal on 1O2 generation emerged in DPBF absorption spectra, and the ESR spectra even after light irradiation for 15 min. With Rose Bengal (RB) as a standard photosensitizer (ΦRB = 0.86 in ethanol), the 1O2 quantum yield of BP nanosheets was up to 0.91. By in vitro experiment, in the coexistence of BP nanosheets and laser irradiation, the cell viability showed a gradual downtrend with increasing the concentration of BP nanosheets (Figure 10c). Dichlorofluorescein (DCF), a cell permeable\nAdv. Funct. Mater. 2019, 29, 1900318\n1900318 (15 of 32) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nfluorescence dye, was employed to detect intracellular ROS production by ultrathin BP nanosheets inside the cancer cells under laser irradiation. The generation of cytotoxic ROS was promoted by BP nanosheets, as manifested from the strong green fluorescence emerging only in the cell group in the presence of both BP nanosheets and laser irradiation (Figure 10d). MDA-MB-231 breast tumor-beared Balb/c nude mice were intratumorally injected with different samples. Only the mice treated with both BP nanosheets and laser irradiation showed an obvious decrease in the volume of tumor (Figure 10e,f). This study fully demonstrated the excellent photodynamic effect of ultrathin BP nanosheets, providing great promising for extensively exploring the PDT of BP nanosheets toward cancer.\nAlthough BP nanosheets have already been proven to possess the particular PDT effect, low oxygen supply in solid tumor still hindered their PDT therapeutic efficiency. RhB (R)-encapsulated manganese dioxide/few-layer BP nanosheets (R-MnO2-FBP) hybrid provided an opportunity to solve this problem.[103] In the acidic environment inside cancer cells, R-MnO2-FBP was dissolved to generate Mn2+ that could convert endogenous hydrogen peroxide (H2O2) to oxygen, relieving the tumor hypoxia specifically. After the addition of R-MnO2-FBP for 8 h, the liberation of Mn2+ and O2 release inside Hela cells reached their maximum. Following 660 nm laser irradiation for 3 min, Hela cells displayed up to 78.9% apoptotic rate. After the treatment of laser irradiation, the tumor in the model mice with R-MnO2-FBP injection reduced to 10% while those with FBP treatment only decreased to 41%. The designed R-MnO2FBP strategy took advantage of oxygen self-supply to markedly enhance the PDT therapeutic efficacy of BP nanosheets. Another similar PDT approach based on BP nanosheets has also been reported in which folate was anchored on BP nanosheets to target tumor lesion with the intention of avoiding the nonspecific distribution of BP photosensitizer.[104] A blocker DNA duplex of 5´-Cy5-aptamer-heme/3´-heme labeled oligonucleotides was functionalized on BP nanosheets for dual-triggered oxygen self-supply in tumor. After the folate-mediated endocytosis of BP composites into cancer cells, the intracellular ATP specially combined with its aptamer on DNA duplex to release Cy5 labeled DNA for in vivo fluorescence imaging. Meantime,\nAdv. Funct. Mater. 2019, 29, 1900318\nFigure 9. Comparison of the photothermal destruction of C6 and MCF7 cancer cells upon addition of BPQDs (0, 25, or 50 ppm) and irradiation with an 808 nm laser at 1.0 W cm−2 for 10 min. a) Fluorescence images of cells stained with calcein AM (live cells, green fluorescence) and PI (dead cells, red fluorescence); b) relative viabilities of C6 cells and MCF7 cells after the various treatments. Reproduced with permission.[47] Copyright 2015, WileyVCH. In vivo photothermal therapy. c) Time-dependent temperature increase. d) Typical photograph of the MCF7 breast tumor-bearing nude mice irradiated by the 808 nm and 1.5 W cm−2 NIR laser for 10 min after intravenous injection of bare BPs and NB@BPs. Reproduced with permission.[79] Copyright 2017, American Chemical Society.\n1900318 (16 of 32) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nthe heme dimer was disassembled to recover their catalytic activity toward endogenous H2O2, achieving synergistic oxygenated behavior. Through laser irradiation, in vitro and in vivo experiments showed an enhanced and lasting PDT effect. Considering the limited penetration depth of the irradiation wavelength located in the visible light region, the upconversion nanoparticles (UCNP) conjugated BP nanosheets (UCNP-BP) was proposed, and different laser irradiation (650, 808, and 980 nm wavelength) were introduced to explore its optimized PDT performance.[105] Both in vitro and in vivo experiments revealed that for the group pretreated with UCNP-BP composites, 808 nm NIR light irradiation generated the largest amount of ROS and exerted the strongest tumor inhibition effect. Similar to BP nanosheets, BPQDs have also been regarded as PDT agents for tumor treatment.[106] Under 670 nm laser irradiation, BPQDs exhibited excellent 1O2-generated ability. The coexistence of laser irradiation and BPQDs promoted the explosive generation of ROS, which therefore induced the death of cancer cells. With S180 tumor bearing BALB/c nude mice as models, it was shown that the remarkable PDT effect of BPQDs significantly inhibited the tumor growth. Most importantly, BPQDs with the hydrodynamic diameter of sub-6 nm were highly desirable for the rapid renal clearance. Over 65% BPQDs were cleared into the urine at 8 h postinjection, significantly verifying the superior biosafety of BPQDs as PDT agents."
    }, {
      "heading" : "4.3. Synergistic Therapy",
      "text" : "With regards to the clinical disease treatment, chemotherapy is considered to be the simplest and most direct strategy. However, the random distribution of drug molecules through the\nAdv. Funct. Mater. 2019, 29, 1900318\nFigure 10. a) Time-dependent absorption spectra of the DPBF with BP nanosheets in air. b) ESR spectra of BP nanosheets in the presence of TEMP in different conditions. Both the decomposing of DPBF and ESR spectra were carried out under Xe lamp with 600 nm cutoff filter. c) Cell viability treated by different concentrations of ultrathin B.P. nanosheets with and without laser irradiation. d) Oxidized DCF fluorescence in cell under different conditions. e) Timedependent tumor growth and f) the imaging of tumors with different treatments. Adapted with permission.[50] Copyright 2015, American Chemical Society.\n1900318 (17 of 32) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\norganism poses a huge threat to normal tissues and organs. On the other hand, in order to achieve the ideal therapeutic effect, the patients usually need take drug several times in succession, greatly increasing the economic burden of the patients. Nanomaterials-based smart drug delivery system, like a navigation-covered chemotherapy, guides drug molecules to selectively accumulate in the lesion, significantly improving the efficacy and reducing the side effect of chemotherapy. Most importantly, some optoelectronic properties of nanomaterials, together with smart drug delivery platform, give rise to synergistic therapeutic effect toward disease.[107]"
    }, {
      "heading" : "4.3.1. Photothermal-Enhanced Chemotherapy",
      "text" : "In the development of smart drug delivery, controllable drug release is a critical point in improving the therapeutic efficiency. Nano-BP, benefiting from their high biosafety and larger specific surface area, has shown the promising prospect in the design of smart drug delivery platform. Tao et al. demonstrated the potential of BP nanosheets as a delivery vehicle.[108] Doxorubicin (DOX) and cyanine7 (Cy7) were co-loaded on PEGylated BP nanosheets to form a robust drug delivery platform for chemotherapy and in vivo near-infrared (NIR) imaging. Folic acid (FA) was introduced simultaneously to PEGylated BP nanosheet for the target recognition toward cancer cells. The colocalization experiment showed that macropinocytosis and caveolae-dependent pathways were the main ways of the internalization of PEGylated BP nanosheets into cancer cells, which provided some essential guidance for understanding the BP-based cancer theranostics. The covalent bonding of Sgc8 aptamer on BP nanosheets@PEG attained the highly specific recognition toward the acute lymphoblastic leukemia, and enhanced the endocytosis of drug carriers into cells by a receptor-mediated manner.[109] The combination of both PTT of PEGylated BP nanosheets and chemotherapy of DOX triggered the remarkable tumor-inhibited effect. Besides BP nanosheets as the nanocarrier, NIR photothermal effect of BP nanosheets timely contributed to the controlled release of drug.[97,110] The thermal-responsive BP@hydrogel nanostructures with DOX encapsulated inside displayed improved cancer therapy.[111] NIR photothermal effect of BP nanosheets softened and melted DOX-loaded BP@hydrogel, resulting in the DOX release. By regulating the intensity and exposure time of NIR light, the release rate of DOX from the BP@hydrogel was accurately controlled. By local intratumoral injection of different samples into tumor-beared mice, BP@hydrogel group displayed a more sustained drug distribution around tumor site than only DOX group, as well as the enhanced tumor ablation effect. Moreover, the histological analysis of the major organs of mice with BP@ hydrogel treatment also showed no observable side toxicity to normal tissues. Lipid-BPQDs bilayer vesicles with DOX encapsulated inside was another interesting NIR light-controlled drug delivery system.[107b] BPQDs adsorb NIR light to generate heat that destroyed the lipid membrane, resulting in the DOX release from lipid-BPQDs vesicles. The DOX release came to a halt when the laser irradiation was off.\nNano-BP can also be applied to promote the bone regeneration. Yang and coworkers have constructed a BP\nnanosheets-reinforced 3D-printed bioglass (BP-BG) scaffold (namely BP-BG scaffold), not only achieving the photothermal ablation toward osteosarcoma, but also promoting the subsequent bone regeneration.[112] The typical principle was displayed in Figure 11a,b. BP nanosheets were integrated onto the surface of BG scaffolds to form BP-BG scaffolds, in which water-free environment was critical for limiting the biodegradation of BP. BP-BG scaffolds were implanted into the center of the osteosarcoma tissues of tumor-bearing mice. The remarkably photothermal behavior of BP nanosheets implemented the hyperthermia-induced osteosarcoma ablation. More intriguingly, the biodegradation of BP nanosheets generated a large amount of PO43− to the body fluid environment, followed by the biomineralization reaction to accelerate the formation of calcium phosphate (CAP) nanoparticles. Taking advantage of the excellent osteogenic performance of CAP nanoparticles, the subsequent bone regeneration was achieved. The male Sprague-Dawley rats were selected as cranial defect models to assess the osteogenic performance of BP-BG scaffolds. The typical micro-CT images and 3D reconstruction of micro-CT images evidenced that BP-BG scaffolds featured much better repairing behavior toward bone defects than pure BG scaffolds (Figure 11c–e). The histomorphometric micro-CT analysis significantly supported the indispensable role of BP nanosheets in enhancing the osteogenic performance. The as-designed BP-BG scaffolds provided a stepwise countermeasure for osteosarcoma therapeutics. With thermosensitive poly (lactic-co-glycolic acid) (PLGA) as nanocarriers to encapsulate both BPQDs and bioactive SrCl2 inside, the developed BPQDs-SrCl2/PLGA drug delivery system was tested to perform the bone regeneration.[113] The NIR irradiation-depend photothermal behavior of BP nanosheets resulted in the Sr2+ release at optimal time, thereby achieving the precise therapy of bone regeneration. Afterward, it was found that mild heat from low intensity and periodic NIR irradiation-mediated BP@PLGA efficiently facilitated the upregulation of heat shock proteins and finally favored the bone regeneration in vitro and in vivo.[114]\nMoreover, BP nanomaterials can also be regarded as a neuroprotective nanomedicine against neurodegenerative disease.[115] The principle was illustrated in Figure 12a. BP nanosheets have strong binding toward copper ions (Cu2+), which can significantly reduce the generation of cytotoxic ROS induced by copper dyshomeostasis, thereby protecting neuronal cell from being damaged. Most importantly, based on in vitro blood-brain barrier (BBB) model and Evans blue staining-employed in vivo experiment, the penetration of BBB was noticeably enhanced by the photothermal performance of BP nanosheets, enabling the therapeutic efficacy of BP nanosheets as nanomedicine (Figure 12b–f). Moreover, the injection of BP nanosheets did not bring in any damage to the major organs of the mice. After 7 d, the brain of experimented mice was examined by MRI and no cerebral thrombosis was checked, which substantiated the biosafety of BP nanosheets as nanomedicine."
    }, {
      "heading" : "4.3.2. Synergistic Photo/Chemo/Genetherapy",
      "text" : "Nano-BP has been widely reported to possess excellent the PTT and PDT.[47,50] Yang et al. has immobilized iron\nAdv. Funct. Mater. 2019, 29, 1900318\n1900318 (18 of 32) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\noxide (Fe3O4) nanoparticles and Au nanoparticles onto BP nanosheets to prepare a BPs@Au@Fe3O4 nanocomposite, achieving the combined PTT/PDT of cancer under a low-power laser irradiation, starting the first shot of synergistic phototherapy.[116] Besides, the nano-BP phototherapy together with the photothermal-enhanced chemotherapy showed a\nAdv. Funct. Mater. 2019, 29, 1900318\nFigure 11. a) Schematic illustration of the fabrication of BP-BG scaffolds and b) the stepwise therapeutic principle for osteosarcoma ablation and the followed bone regeneration by BP-BG scaffolds. Micro-CT imaging and analysis of harvested craniums obtained from Sprague-Dawley rats after treatments for 8 weeks. The defect areas were implanted with BP-BG scaffold (left) and BG scaffold (right) for comparison. c) 3D reconstruction of micro-CT images of the cranium based on the density variations of osseous tissue. The two irregular holes in cranial defect areas present that the newborn osseous tissues are too thin to be identified by the 3D reconstruction software. Micro-CT images of circular defect areas of around 5 mm in diameter. The images of d) BP-BG and e) BG group were acquired using black (left) and white (right) substrates. When the color of substrates reversed from black to white, the newborn osseous tissue can be visualized micro-CT images of harvested craniums obtained from the bone defect. Reproduced with permission[112] Copyright 2018, Wiley-VCH.\n1900318 (19 of 32) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nhighly efficient and synergistic therapeutic strategy toward disease (Figure 13a).[117] In contrast to indocyanine green (ICG) (a clinically usable photothermal agent approved by U.S. FDA), BP and BP-DOX exhibited the excellent photostability (Figure 13b). BP nanosheets were used as nanocarriers to load DOX via electrostatic interaction, forming BP-DOX. Benefiting from their puckered lattice configuration, the loading capacity of BP nanosheets toward DOX was as high as 950%, much higher than those of the reported other 2D nanomaterials, such as graphene (Figure 13c). With 808 nm laser irradiation for 20 min, over 90% DOX was released, obviously supporting the enhanced drug release behavior caused\nAdv. Funct. Mater. 2019, 29, 1900318\nFigure 12. a) Schematic illustration of BP nanosheets as BBB a penetrable nanocaptor to decrease the oxidative stress production through capturing Cu ions for ND therapy. b) The photothermal effect of BP nanosheets at different concentration with BP-free water as control. c) The in vitro BBB crossing ability of BP nanosheets promoted by photothermal effect. Insert: schematic illustration of in vitro BBB model. d) The in vivo photothermal effect of BP under 808 nm laser irradiation: 1) BP, 2) NIR, and 3) BP+NIR. e) The photographs of representative brains of mice after the treatments, using Evans blue as BBB integrity indicator. f) The NIR fluorescence imaging of brains after different treatments: 1) Cy5-PEG-BP, 2) Cy5-PEG + NIR, and 3) Cy5-PEG-BP + NIR. Reproduced with permission.[115] Copyright 2018, Wiley-VCH.\n1900318 (20 of 32) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nby photothermal effect. The results from in vivo experiments proved that the advantage of the synergistic photothermal/ photodynamic/chemotherapy for BP-DOX was fully utilized by the treatment of laser irradiation (660 and 808 nm), hence ultimately damaging to cancer cells and achieving the obvious antitumor efficiency (Figure 13d). Meantime, the histological analysis of the major organs did not show any observed damage. Therefore, BP nanosheets-based synergistic therapy strategy provides new perspectives to develop the multifunctional nanomedicine platform, showing substantial promising for future clinical application. Gene therapy can be defined as another chemotherapy which primarily uses nucleic acid polymers as drug. Small interfering RNA (siRNA)-induced gene silencing is the main strategy for the gene therapy.[118] However, bare siRNA exposure to organism faces the challenge of rapid enzymatic degradation and low efficiency of cell uptake. The targeted drug delivery strategy provides a feasible solution to above\nAdv. Funct. Mater. 2019, 29, 1900318\nFigure 13. a) Schematic illustration of BP-DOX for the synergistic therapy of cancer. b) Photostability of BP and BP-DOX in water under 808 nm irradiation (1 W cm−2), ICG was used as control. c) DOX loading capacity of BP nanosheets at various DOX concentrations. d) Tumor growth curves (left) and digital photo of representative tumor (right) in mice after different treatments. Reproduced with permission.[117] Copyright 2017, Wiley-VCH.\n1900318 (21 of 32) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimAdv. Funct. Mater. 2019, 29, 1900318\nproblems.[119] The siRNA delivery system based on PEG and polyethyleneimine (PEI) dual-functionalized BP nanosheets (PPBP) can specifically deliver hTERT small interfering RNA (siRNA) to cancer cells.[120] Positive-charged PEI coating on BP nanosheets provided large amount of binding sites for siRNA with negative charges, preventing siRNA from enzymatic degradation. On the other hand, PEI modification enabled PPBP-siRNA internalization into cells and guided BP-PEI-siRNA escape from the lysosome into the cytoplasm, significantly improving the transfection efficiency of PPBPsiRNA. Hela cells were incubated with PPBP-siRNA for 48 h, followed by being irradiated by 808 and 660 nm lasers. The western blot analysis showed a reduced mRNA expression of hTERT and increased Hsp70 expression, corroborating the gene-silence effect of hTERT siRNA in the PPBP delivery system as well as the remarkable photothermal effect of PPBP. PPBP-induced intracellular ROS generation has also been proven by fluorescence confocal microscopy. Of special note is that PPBP could be gradually degraded in the mixed environment containing low pH and rich ROS, allowing the target delivery of PPBP-siRNA and the release of siRNA to cancer cell. In vitro and in vivo assay demonstrated that under 808 and 660 nm laser irradiation, nearly all Hela cells with PPBP treatment were killed and the tumor-beared mice with treatment of PPBP-siRNA displayed the most obvious tumor suppression without any observable side effects, achieving an excellent synergistic photo/genetherapy. The BP-PEI-siRNA complex with 200 × 10−9 m siRNA dose exhibited around 80% suppression of the surviving protein expression in MCF-7 cancer cells while visible inhibition did not occur to naked siRNA with the same dose.[121] Moreover, for in nude mice bearing MCF-7 tumor xenografts, the treatment of both BPPEI-siRNA and laser irradiation exhibited the stronger tumorinhibited effect during the observation period compared with the group treated only with BP-PEI-siRNA, indicating the enhanced gene therapeutic efficacy induced by photothermal effect of BP nanosheets. On the whole, BP nanosheet-based gene delivery platform provides new insight for broadening the clinical application of gene therapy. Multidrug codelivery system represents a new perspective for innovative cancer therapy, the multidrug-resistant cancer in particular. P-gp siRNA has been reported to downregulate permeability glycoprotein (P-gp) expressions on the cancer cell membrane for against P-gp mediated multidrug resistance. P-gp siRNA together with DOX as a model dual-therapeutic substance was loaded onto BP nanosheets to form a multidrug codelivery system with target chemo/gene/phototherapy.[85] PDA encapsulated BP nanosheets showed enhanced biostability and photothermal performance. The application of aptamer rendered the proposed multidrug codelivery system with specific recognition toward tumor. The proposed multidrug codelivery strategy exhibited the best tumor-inhibited performance, primarily attributable to the enhanced phototherapy effect of PDA/BP nanosheets, photothermal effect-induced drug release of DOX and P-gp siRNA, as well as the inhibition of P-gp siRNA toward drug resistance. This demonstrated that multimodal treatment platform possessed great potential for developing high-efficient cancer suppression strategy."
    }, {
      "heading" : "4.3.3. Chemo-Photoimmunotherapy",
      "text" : "Immunotherapy is by far the most popular strategy for tumor treatment that can not only selectively target tumor cells without any side effect to normal tissues, but also activate immune memory cells to prolong antitumor effect and reduce the risk of tumor recurrence.[122] Intriguingly, the recent study from Toraya-Brown et al. showed that local hyperthermia could promote the activation of the host immune system.[123] The combination of immunotherapy and BP nanomaterialsbased phototherapy therefore boosts the treatment efficiency toward cancer. Figure 14 shows the schematic illustration of the chemo-photoimmunotherapy.[124] In this report, a new method based on plug-and-play nanorization and ultrasonic bubble bursting was applied to produce uniform BP nanosheets with ≈40 nm lateral dimension. DOX (D), folic acid (F), and cancer growth inhibitor of both programmed death ligand 1 (PL) and siRNA (s) were coimmobilized on BP base to form\n1900318 (22 of 32) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimAdv. Funct. Mater. 2019, 29, 1900318\na chemo-photoimmunotherapeutic platform, BP-DcF@sPL, for targeting colorectal cancer treatment. It was shown that BP-DcF@sPL significantly decreased the PL expression of cancer cell owing to the gene silencing effect and the blockades of sPL. Furthermore, being more advantageous relative to the commercial Dharmafect transfection agent (i.e., Dharmafect@ sPL) in terms of reducing PL expression, BP-DcF@sPL represented the feasibility of the immunotherapy effect. For MC-38 tumor-bearing mice, the treatment of both BP-DcF@sPL and NIR irradiation caused ≈37% activated T cells, as well as induced significant elevation in both necrosis (44.1–52.8% due to hyperthermic direct cell death) and apoptosis (28.8–36.3%). In addition, BP-DcF@sPL brought about the higher expression levels of IFN-γ, interfering the PL pathway-regulated immune tolerance and suppression of CD8+ T cell. The fabricated BP-DcF@ sPL configuration not only induced chemo-phototherapy for killing cancer cells, but also utilized PL blockades to interfere the PL pathway-regulated immune tolerance, affording a comprehensive strategy for high-performance cancer treatment. Another typical strategy on PTT-induced tumor neoantigen release in situ was reported, and a biomimetic BPQD-erythrocyte membranes nanovesicle (BPQD-RMNV) was explored for photothermal breast cancer immunotherapy.[125] The NIR irradiation resulted in breast cancer cell apoptosis, and stimulated the immune system to eliminate the residual and metastatic cancer cells. At the same time, the employment of programmed cell death protein 1 antibody (aPD-1) further protected the CD8+ T cells from exhaustion. The synergistic strategy of BPQD-RMNVbased PTT and immune checkpoint blockade of aPD-1 remarkably inhibited basal-like breast tumor growth in vivo."
    }, {
      "heading" : "5. Biosensing Application of Nano-BP",
      "text" : "Apart from the remarkable biomedicine application, nano-BP has also attracted reasonable attention from the biosensing field. Nano-BP with the distinct surface activity and photoelectric performance as well as good biocompatibility can be utilized to functionalize the electrode interface or as specific signal reporters for attaining highly sensitive detection of biological markers."
    }, {
      "heading" : "5.1. Electrochemical Biosensors",
      "text" : "Electrochemical biosensor, as a popular analytical method, has been historically utilized to detect a variety of biomarkers.[126] Generally, electrode materials and signal reporters are the two critical factors in terms of rational design of highly sensitive electrochemical biosensor. The rapid advancement of 2D nanomaterials provides many alternatives for the exploitation of electrochemical biosensor with high performance.[127] Due to their large specific surface area and distinct surface energy, 2D nanomaterials-modified electrode interfaces exhibit high affinity toward biomolecules as well as good biocompatibility for retaining the bioactivity of the absorbed molecules.[128] At the same time, 2D nanomaterials with excellent conductivity can significantly enhance the current signal, and improve the detection sensitivity of electrochemical biosensor. BP nanosheets,\nas a newly emerged 2D nanomaterial, possess the appealing points in electrochemical detection of biomarkers, such as remarkable surface properties,[129,130] good electron transfer conductivity.[131,132] However, the ambient instability of BP nanosheets greatly hampered its performance in electrochemical biosensor to some extent. Currently, considerable efforts have been devoted to improving the stability of BP nanomaterials and optimizing their performance in biosensing application. For example, the pLL modification on the surface of BP nanosheets not only improved the stability of BP nanosheets, but also retained their native structure and original conductivity. Besides, the obtained pLL-BP nanohybrid provided many chemisorption sites for the immobilization of hemoglobin (Hb) with negative charges. As presented in Figure 15, the pLL-BP nanohybridbased enzymatic biosensor displayed considerable feasibility in electrochemical detection of H2O2.[129] Hb-pLL-BP-GCE presented an obvious reversible current response because pLL-BP nanohybrid provided a perfect matrix for the direct electron transfer of Hb (Figure 15b). In the absence of BP nanosheets, Hb-pLL-GCE displayed a rather weak redox peak, strongly indicating that the introduction of BP not only facilitated the Hb loading, but also enhanced the electrochemical activity of biointerface. The redox center of ferric/ferrous in Hb protein exhibited excellent catalytic activity for the reduction of H2O2 (Figure 15c). Combined with the unique honeycomb structure and metallic character of BP, Hb-pLL-BP-GCE exhibited better electrocatalytic performance toward reduction of H2O2 (Figure 15d), achieving a good linear relationship for different concentration of H2O2 ranging from 10 × 10−6 to 700 × 10−6 m.\nOn the other hand, a label-free electrochemical biosensor based on aptamer-functionalized pLL-BP nanostructure was also explored for direct detection of cardiac biomarker myoglobin (Mb).[130] Through Coulombic interactions between PLL and DNA, anti-Mb DNA aptamers were bound onto the surface of pLL-BP nanostructure for the specific capture of Mb. Inside of Mb contains a heme group with an iron(II) center that can be directly regarded as an electrochemical redox site for producing electrochemical signals. The inherent redox property of BP nanosheets greatly amplified the electrochemical response of the proposed electrochemical biosensor and improved its detection sensitivity toward Mb, achieving an excellent linear range from 1 pg mL−1 to 16 µg mL−1 with a detection limit of ≈0.137 pg mL−1. In comparison to reduced graphene oxide-based aptamer biosensor for Mb assay with a detection limit of ≈1.3 ng mL−1, the demonstrated pLL-BP nanostructure-based electrochemical aptasensor exhibited the comparative superiority. Besides, BP nanosheets with high hole mobility integrated with the conducting poly(3,4-ethylenedioxythiophene)-poly(styrenesulfonate) (BP-PEDOT:PSS) to form BP-PEDOT:PSS nanocomposites. The obtained BP-PEDOT:PSS nanocomposites exhibited much better conductivity than bare PEDOT:PSS. The electrochemical biosensor based on BP-PEDOT:PSS interface displayed a strong binding affinity toward Hb, achieving appreciably sensitive detection of Hb.[132] Compared with BP microparticles, BP nanoparticles (BP NPs) possessed the enhanced electrocatalytic activity in hydrogen evolution reaction at more positive potentials.[133] In light of this, BP NPs, employed as electrocatalytic signal tags, were proposed a magnetic bead-based competitive immunosensor for quantitative detection of rabbit IgG via hydrogen\n1900318 (23 of 32) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimAdv. Funct. Mater. 2019, 29, 1900318\nevolution mediation. With nanoimpact electrochemistry as analytical method, BP NPs were directly detected by hydrogen evolution reaction, further achieving the quantitative assay of rabbit IgG with a low detection limit of 0.98 ng mL−1. Relative to the system reported for gold nanoparticles, the developed competitive immunosensor with BP NPs as electrocatalytic signal tags showed the extraordinary analytical performance.\nIt is known that the lone pair electrons of phosphorus atoms on the surface of nano-BP are the preferential adsorption sites for oxygen, ultimately leading to oxidative degradation of nanoBP. Thus, the follow-up block to electrochemical conductivity of BP nanosheets caused by the oxidative degradation was another strategy for electrochemical detection of H2O2.[134] In order to avoid the oxidative degradation of BP induced by non-H2O2 species, the well-prepared BP nanosheets-modified electrode (BP electrode) was stored in N2-saturated PBS solution in advance. Herein, cyclic voltammogram (CV) and electrochemical impedance were used to monitor the electrochemical behavior of BP electrode toward H2O2. It was shown that the presence of H2O2 was directly correlated with the decrease of\nCV area and the increase of electrochemical impedance, both of which were ascribed to the degradation of BP nanosheets. The developed BP-based H2O2 sensor reached the lower detection limit of 1 × 10−7 m and exhibited considerable sensitivity toward H2O2 detection. The design concept on a basis of the ease-todegradation of BP nanosheets provides a new insight for the extensive study of BP nanomaterials."
    }, {
      "heading" : "5.2. Field Effect Transistor Biosensor",
      "text" : "FET biosensors, due to their high miniaturization and integration, have sparked tremendous attention from the life science.[135] For the FET biosensor, the working mechanism is based on the conductance change of FET channel after the binding of target analytes. Meanwhile, the sensitivity of sensing channel plays a key role with respect to the design of high performance FET biosensors. 2D nanomaterials, owing to their exceptional biocompatibility, adsorption toward target molecules, surface property and electronic sensitivity, have been widely\nFigure 15. a) The principle of pLL-BP nanohybrid-based electrochemical biosensor for H2O2 detection. b) Cyclic voltammograms (CVs) of Hb-pLLBP-GCE, pLL-BP-GCE, and Hb-pLL-GCE in 20 × 10−3 m pH 7.5 PBS. CVs of c) Hb-pLL-BP modified electrode and d) pLL-BP, Hb-pLL, and Hb-pLL-BP modified electrode in 20 × 10−3 m pH 7.5 PBS saturated with N2 before and after adding 2 × 10−3 m H2O2. Adapted with permission.[129] Copyright 2018, American Chemical Society.\n1900318 (24 of 32) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimAdv. Funct. Mater. 2019, 29, 1900318\nutilized as sensing channel to enhance the sensitivity of FET biosensors.[136] BP nanosheets with wide bandgap range (0.3 eV for bulk BP to 2.0 eV for monolayer BP) and high carrier mobility (1000 cm2 V−1 s−1) have been selected as an ideal candidate for the development of high-performance FET sensing platform.[137] Few-layers BP nanosheets have been reported as sensing channel for the design of FET biosensors.[138] As illustrated in Figure 16a, Al2O3 thin film deposited was utilized to protect BP channel from oxidative degradation in aqueous solution and simultaneously for the immobilization of gold nanoparticles labeled antihuman IgG antibody. Due to the specific interaction of antibody and antigen, the attachment of IgG antigens onto the BPFET biosensor obviously resulted in a negative gate potential, inducing the increase of drain–source current correspondingly. For different concentration of IgG antigens ranging from 10 to 500 ng mL−1, the designed BPFET biosensor displayed good response with a low detection limit of ≈10 ng mL−1 (Figure 16b,c). This study presented a clear image of the great potential of BP nanosheets as sensing channel of FET biosensor for highly sensitive and selective detection of biomarkers."
    }, {
      "heading" : "5.3. Fluorescence Biosensor",
      "text" : "Apart from electrochemical biosensor, fluorescence (FL) biosensor has also been extensively used for biomolecules\nFigure 16. a) Schematic illustration of BP FET biosensor for IgG detection. b) Dynamic response of the sensor for different concentrations of IgG. c) Plotting of sensitivity as a function of target protein concentration. Specific binding of IgG molecules on the device leads to the highest sensitivity compared with the devices without probes and with nonspecific proteins. Adapted with permission.[138] Copyright 2017, Elsevier.\n1900318 (25 of 32) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimAdv. Funct. Mater. 2019, 29, 1900318\ndetection, in which quantitative assay of target analytes was specifically achieved according to the produced FL signals.[139] The introduction of nanomaterials have contributed mostly to the diversity of FL biosensors and various structures of nanomaterials, to some extent, can be designed to rationalize the express of FL signal such as FL enhancement or FL quenching.[140] BP nanomaterials, as one of the most popular nanomaterials, have also stimulated researchers to investigate their application in FL biosensing platform.[141–144]\nIn the development of BP nanomaterials-based FL biosensor, BPQDs was the preferred one. It has been evidenced that BPQDs not only exhibited green FL with a quantum yield of up to 8.4%, but also possessed remarkable photostability as well as relative pH resistance. Interestingly, the emission peak of BPQDs revealed an apparent red-shift from 491 nm to 521 nm with the excitation wavelength increasing. The maximum emission of BPQDs emerged at 497 nm under the excitation of 390 nm.[141] In view of the inner filter effect (IFE) between BPQDs and 2-nitro-5-thiobenzoate anion (TNB), BPQDs-based FL sensing strategy has already achieved the specific detection of thiol-contained biomolecules, as depicted in Figure 17a.[142] In the presence of thiol-containing biomolecules, 5,5-dithiobis(2-nitrobenzoic acid) (DTNB) (Ellman’s reagent) reacted with thiol group to form TNB that displayed a considerable spectra overlapping with the excitation spectrum of the as-synthesized BPQDs, thereafter leading to the FL quenching of BPQDs. Acetylcholinesterase (AChE) is known as an important biological enzyme. It can promote neuronal development and nerve regeneration, significantly contributing to the neurological diseases diagnostics. As illustrated in Figure 17b, AChE can efficiently catalyze acetylthiocholine (ATCh) to generate the thiocholine (TCh). TCh with a thiol group, followed by inducing the generation of TNB by the reaction with DTNB and the fluorescence quenching of BPQDs. Along with the increase in AChE activity, more TCh was produced, and the FL quenching of BPQDs became more pronounced. The demonstrated BPQDs-based FL biosensor showed a considerable sensitivity toward AChE activity from 0.2 unit L−1 to 5.0 unit L−1 with a detection limit of 0.04 unit L−1 (Figure 17c,d). BP nanoparticles (BPNPs) have ever been evidenced to display maximum FL emission at 527 nm under the excitation wavelength of 200 nm, based on which a DNA biosensor with the employment of BPNPs as FL signal reporters was proposed.[143] Typically, dabcyl was used as the dark quencher to label single-stranded DNA, forming dabcyl-Lprobes. By hydrophobic interaction and dispersive forces, the adsorption of dabcyl-Lprobe on the surface of BPNPs directly quenched the FL of BPNPs. The existence of target complementary DNA (cDNA) promoted the formation of the double-stranded DNA complexes by the hybridization with dabcyl-Lprobe, causing the desorption of dabcyl-Lprobe from BPNPs and probable FL recovering of BPNPs.\nOn the other hand, BP nanosheets without FL exhibit distinctive FL quenching effect, which has already been utilized as FL quenching agents to achieve the rapid microRNA (miRNA) assay.[144] Fluorescein FAM labeled ssDNA (pDNA) acted as an FL probe. Through the van der Waals force between nucleobases and the P atoms of BP, pDNA was strongly adsorbed onto BP nanosheets, inducing the FL quenching of FAM through the fluorescence resonance energy transfer. The\naddition of miRNA promoted the hybridization with pDNA and the release of pDNA from BP nanosheets, thereby recovering the FAM fluorescence. BP nanosheets-based FL biosensor presented a simple and rapid detection process toward miRNA, and achieved a wide linear range from 10 × 10−9 to 1000 × 10−9 with a detection limit of 9.37 × 10−9. The same principle was also applied for the protease assay and inhibitor screening.[145] BP nanosheets can efficiently quench the FL of perylene probe via electrostatic interaction. The competitive adsorption of cationic histone onto BP nanosheets facilitated the release of perylene probes, resulting in its FL recovery. However, in the presence of the protease (trypsin), the histones were degraded into peptide fragments, and then its adsorption on the surface of BP nanosheets was lost, simultaneously blocking the FL recovery of perylene probes. The introduction of protease inhibitors (i.e., benzamidine hydrochloride and the inhibitor from soybean) into the designed FL biosensing system inhibited the hydrolysis of protease toward histone, subsequently influencing the FL recovery of perylene probes."
    }, {
      "heading" : "5.4. Chemiluminescence Biosensor",
      "text" : "Inspired by the extensive application of BP nanomaterials in electrochemical sensor, FET electric device and FL sensor, Liu and coworkers thoroughly explored the unique structure and photoelectronic properties of BPQDs, and discovered that BPQDs exhibited interesting chemiluminescence (CL) behavior in the presence of hydrogen peroxide (H2O2) and hypochlorite (ClO−).[146] The CL behavior of BPQDs was analyzed by the CL kinetic curves. It was demonstrated that the addition of ClO− into the H2O2 solution only generated a weak CL peak, as opposed to remarkably enhanced CL intensity as ClO− was introduced into the mixture of BPQDs and H2O2. For the mixture of either ClO− or H2O2 with BPQD, both of the CL signals were very weak. The above phenomenon confirmed that BPQDs and some H2O2-ClO− related species were indispensable in the BPQDs-H2O2-ClO− CL system. In order to illustrate the mechanism of BPQDs-H2O2-ClO− CL system, and figure out the active intermediates during the CL reaction, four different trapping agents, including sodium azide (NaN3) for 1O2, ascorbic acid (AA) for free radicals, thiourea for •OH and nitro blue tetrazolium chloride (NBT) for •O2−, were introduced into BPQDs-H2O2-ClO− reaction, respectively, all of which resulted in the evident decrease of CL signal, evenly total quenching. The mechanism was further confirmed via room-temperature electron spin resonance (ESR) spectroscopy as well as fluorescence characterization, both of which clearly showed the •OH generation in H2O2-ClO− system and the existence of the reaction between •OH and BPQDs in BPQDs-H2O2-ClO− system. Similarly, the generation and depletion of 1O2 in the H2O2ClO− reaction with and without BPQDs have been verified by ESR spectra and chemical trapping measurement. According to the reports from Fujiwara and Kazuko,[147] HPO, a class of high-energy phosphorous oxides, have been regarded as pivotal intermediates in many gas-phase CL reactions. For the proposed BPQDs-H2O2-ClO− CL system, it has also been verified that the HPO intermediates still existed. A targeted CL mechanism of BPQDs-H2O2-ClO− system was proposed based on the\n1900318 (26 of 32) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimAdv. Funct. Mater. 2019, 29, 1900318\nforegoing analysis and discussion (Figure 18). In the CL system, •O2− radical, •OH and 1O2 have been historically regarded as critical oxidants. In this case, the oxidation of BPQDs caused by ROS remarkably promoted the generation of high energy HPO with the CL emission of 530 nm (reaction (7)). By utilizing the resulting BPQDs CL system, a comparable detection range of H2O2 was obtained from 0.50 to 50 mmol L−1 with a detection limit of 0.168 × 10−3 m."
    }, {
      "heading" : "5.5. Electrogenerated Chemiluminescence Biosensor",
      "text" : "Electrogenerated chemiluminescence (ECL) as a powerful analytical approach has been widely used to detect various biomolecules and disease biomarkers.[148] Ru(bpy)32+ ECL is a coreactant ECL system wherein the introduction of the coreactant can significantly enhance the ECL signal.[149] The commonly used coreactants are a class of water-solute small molecules, mainly\nFigure 17. The schematic demonstration of BPQDs-based fluorescence sensing strategy toward a) thiol detection and b) AChE activity based on IFE mechanism. c) Quantitative detection of different concentration of AChE (0, 0.20, 0.40, 0.60, 0.80, 1, 1.5, 2, 2.5, 3, 3.5, 4, 5, 6, 10, 15, 20 unit L−1) with the developed FL biosensing system. d) The linear relationship between FL intensity and the AChE activity. Reproduced with permission.[142] Copyright 2017, Elsevier.\n1900318 (27 of 32) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimAdv. Funct. Mater. 2019, 29, 1900318\nincluding oxalate, alkylamines and NADH, but their inherent biological toxicity largely limits the detection sensitivity of ECL biosensor. As alternatives, some semiconductor quantum dots have been proved to act as the coreactants for enhancing ECL signal.[150] BPQDs, as a novel quantum dots, are characteristic of numerous spectacular physicochemical properties and superior biocompatibility. The ECL behavior of BPQDs as the coreactant was first explored in Ru(bpy)32+ ECL system.[151] The BPQDs modified glassy carbon electrode (BPQDs-GCE) exhibited a strong anodic ECL signal in neutral condition, while the ECL signal from the bare GCE electrode was extremely weak. The CV behaviors of the BPQDs-GCE and bare GCE electrode showed the consistent result with the above ECL experiment (Figure 19a,b). BPQDs could be used as the coreactant of Ru(bpy)32+ ECL system to achieve the enhanced ECL signal. However, the introduction of dopamine (DA) signi ficantly inhibited the Ru(bpy)32+ ECL signals (Figure 19c). Based on the above consideration, the fabricated BPQDs/GCE was applied to detect a series of dopamine solution with different concentration, achieving a good linear relation ranging from 0.1 × 10−9 to 50 × 10−9 m with a low detection limit of 0.022 × 10−9 m (Figure 19d). Layered BPNSs were then explored,[152] showing that with tripropylamine (TPrA) as a coreactant, the BPNS modified glassy carbon electrode (BPNS/GCE) generated a strong anodic ECL signal under neutral conditions. Hydrogen peroxide (H2O2) displayed an obvious inhibiting effect on the typical anodic ECL signal. According to the principle, BPNSbased ECL biosensor attained highly sensitive detection of H2O2."
    }, {
      "heading" : "5.6. Colorimetric Biosensor",
      "text" : "Colorimetric biosensor is a simple and intuitive method for biomolecules assay. Quantitative detection of biomarkers can be achieved by distincting the generated color signal with naked eyes or a simple absorption spectra device.[153] A commonly used type of signal label, gold (Au) nanoparticles with\ninherent red color, has been widely applied to detect various biomarkers.[154] BP nanosheets did not possess the dazzling color features, but exhibited the feature for colorimetric detection of carcinoembryonic antigen (CEA).[155] Here, the instability of BP nanosheets was utilized for enhancing catalytic activity, and fabricating a few-layer BP/Au (FL-BP/Au) colorimetric sensing platform. The main principle of the proposed strategy was based on the unique catalytic activity in reducing the yellow 4-nitrophenol (4-NP) to the colorless 4-aminophenol (4-AP). Nevertheless, through the hydrophobic interaction and the van der Waals force between protein and Au NPs, anti-CEA antibody was absorbed robustly on the surface of FL-BP/Au nanohybrids, significantly inhibiting the catalytic activity of BP-Au toward yellow 4-NP. Upon the presence of CEA, the remarkably specific binding between antigen and antibody obviously shifted the absorption equilibrium between anti-CEA and FL-BP/Au nanohybrids, promoting the anti-CEA release from FL-BP/Au nanohybrids and the retention of the catalytic activity of FL-BP/Au. The proposed colorimetric biosensor showed excellent analytical performance for CEA, achieving a low detection limit of 0.2 pg mL−1. Moreover, in the detection of clinical human serum samples, the designed biosensing system presented the satisfactory results, strongly supporting the practical application of FL-BP/Au biosensing platform."
    }, {
      "heading" : "6. Conclusion and Outlook",
      "text" : "This review article provides a comprehensive summary on the recent progress on preparation, functionalization, and applications in biomedicine and biosensing of layered BP. Since fewlayer BP was mechanically exfoliated from bulk BP crystal in 2014, large amount of studies have been carried out to explore the related application in biomedicine and biosensing. In this process, a variety of synthetic methods came into being. Mechanical cleavage and liquid phase ultrasonic exfoliation are the commonly used methods for layered-BP preparation. Besides, electrochemical exfoliation, solvothermal treatment, milling crushing and acoustic-microfluidic stripping were also applied. 2D BP nanosheets, BPQDs and BP nanoparticles are the three most popular forms of layered BP. The unusual advantages of layered BP set it stand out from 2D nanomaterials. For instance, the tunable bandgap is the most representative feature of layered BP, which endows layered BP a strong absorption across the entire near infrared region. Besides, layered BP possesses a relatively high carrier mobility while its on/off ratio is maintained at reasonable level. Thus, as a desirable sensing channel, layered BP has attracted much interest for the fabrication of highly sensitive FET biodevices. Layered BP displays a layer-dependent PL effect. Upon 808 nm laser irradiation, layered BP exhibits excellent photothermal conversion efficiency. In view of the above features, layered BP has been widely used to FL bioimaging, thermal imaging and PA imaging. Ultrathin layered BP irradiated by 660 nm laser generates the cytotoxic ROS, indicative of remarkable photodynamic effect. Therefore, layered BP, as an ideal nanomedicine, achieves the combined cancer treatment of both PTT and PDT. Apart from the special optoelectronic properties, the puckered honeycomb structure renders layered BP a large surface area,\n1900318 (28 of 32) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimAdv. Funct. Mater. 2019, 29, 1900318\nenabling a high loading toward drug and imaging agents. Most importantly, the photothermal effect of layered BP contributes to the drug release and the timed drug release can be regulated by controlling the duration of laser irradiation. Together with PTT and PDT, layered BP-based drug delivery system exhibits a synergistic therapeutic efficacy of disease. Besides, in biosensing application, benefiting from the good electrochemically catalytic activity, layered BP-based electrochemical biosensors display high sensitivity. The unique fluorescence property of BPQDs and the fluorescence quenching of 2D BP nanosheets have been utilized to fabricate various fluorescence biosensors. It is more exciting that BPQDs involved H2O2-ClO-CL system shows enhanced CL behavior, providing a new approach for H2O2 detection. In the Ru(bpy)32+ ECL system, BPQDs are an ideal coreactant and obviously improve the ECL signal in dopamine assay. In the light of the catalytic activity of BP/ Au nanocomposites toward 4-NP, layered BP colorimetric biosensor has also been successfully designed. Despite the above advances, the synthesis and applications in biomedicine and biosensing of layered BP still face many challenges. First, nearly all the synthesized methods of layered BP were based on the top-down strategy, and the obtained layered BP did not exhibit controllable size and ultrathin structure, as well as the reliable stability. Exploring the efficient and novel\nFigure 19. a) CVs and b) ECL behavior of Ru(bpy)32+ at a bare GCE and a BPQDs/GCE under neutral conditions. c) ECL curves of Ru(bpy)32+ at the BPQDs/GCE with and without DA. d) The effect of DA concentration on ECL intensity. Adapted with permission.[151] Copyright 2018, The Royal Society of Chemistry.\n1900318 (29 of 32) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimAdv. Funct. Mater. 2019, 29, 1900318\nsynthetic approach is still urgent to get high-quality layered BP. Second, the instability of layered BP against ambient environment greatly hampers its photothermal effect and optoelectronic property. Physical encapsulation and chemical modification have been employed to protect layered BP from being degraded. On the other hand, the ambient instability of layered BP means the good biodegradation in biological organism, which can effectively reduce the damage to normal tissues and organs caused by the aggregation of nanocarriers in the body. How to balance the stability and biodegradation of layered-BP is critical for achieving the best therapeutic efficacy and the minimal residual in organism. Moderate modification to layered BP may be a good solution. Third, the previously reported layered BP-based biomedical application excessively confined in cancer-related disease, although there are several reports on bone regeneration and neurodegenerative disease. Some other diseases should be considered to broaden the potential application of layered BP, for instance, cardiovascular diseases. Finally, compared with other 2D nanomaterials, the biosensing exploration of layered BP is still in the infancy. The functional strategy of nano-BP was mainly concentrated on polymer modification. The developed BPFET biodevice was not widely used to detect biological samples. The exploitation of multifunctional layered BP nanocomposites and various portable BPFET biodevices will provide great promise for the development of innovative BP biosensing platform."
    }, {
      "heading" : "Acknowledgements",
      "text" : "This work was financially supported by the Beijing Natural Science Foundation (No. JQ18005), National Key R&D Program of China (No. 2016YFB0100201), National Natural Science Foundation of China (No. 51671003), BIC-ESAT funding, and the China Postdoctoral Science Foundation (No. 2018M630021).\nConflict of Interest The authors declare no conflict of interest.\nKeywords 2D materials, biomedicine, biosensing, black phosphorus\nReceived: January 11, 2019 Revised: April 23, 2019 Published online: May 10, 2019\n[1] a) C. Tan, X. Cao, X. Wu, Q. He, J. Yang, X. Zhang, J. Chen, W. Zhao, S. Han, G. Nam, M. Sindoro, H. Zhang, Chem. Rev. 2017, 117, 6225; b) Y. Chen, C. Tan, H. Zhang, L. Wang, Chem. Soc. Rev. 2015, 44, 2681. [2] a) H. Zhang, ACS Nano 2015, 9, 9451; b) Y. Cheng, R. Wang, J. Sun, L. Gao, Adv. Mater. 2015, 27, 7365. [3] Z. Wang, W. Zhu, Y. Qiu, X. Yi, A. Bussche, A. Kane, H. Gao, K. Koski, R. Hurt, Adv. Mater. 2016, 45, 1750. [4] Y. Wang, M. Zhao, J. Ping, B. Chen, X. Cao, Y. Huang, C. Tan, Q. Ma, S. Wu, Y. Yu, Q. Lu, J. Chen, W. Z. Y. Ying, H. Zhang, Adv. Mater. 2016, 28, 4146.\n[5] H. Jiang, Small 2011, 7, 2413. [6] a) C. Lee, X. Wei, J. Kysar, J. Hone, Science 2008, 321, 385;\nb) Y. Zhu, S. Murali, W. Cai, X. Li, J. Suk, J. R. Potts, R. S. Ruoff, Adv. Mater. 2010, 22, 3906; c) L. Tang, Y. Wang, J. Li, Chem. Soc. Rev. 2015, 44, 6954; d) V. Biju, Chem. Soc. Rev. 2014, 43, 744. [7] a) A. K. Geim, K. S. Novoselov, Nat. Mater. 2007, 6, 183; b) K. V. Krishna, C. Menard-Moyon, S. Verma, A. Bianco, Nanomedicine 2013, 8, 1669; c) S. Stankovich, D. A. Dikin, G. H. B. Dommett, K. M. Kohlhaas, E. J. Zimney, E. A. Stach, R. D. Piner, S. T. Nguyen, R. S. Ruoff, Nature 2006, 442, 282. [8] a) C. Lu, H. Yang, C. Zhu, X. Chen, G. Chen, Angew. Chem., Int. Ed. 2009, 48, 4785; b) L. Feng, Y. Chen, J. Ren, X. Qu, Biomaterials 2011, 32, 2930; c) S. Xu, Y. Liu, T. Wang, J. Li, Anal. Chem. 2011, 83, 3817; d) S. He, B. Song, D. Li, C. Zhu, W. Qi, Y. Wen, L. Wang, S. Song, H. Fang, C. Fan, Adv. Funct. Mater. 2010, 20, 453. [9] H. Jang, Y. J. Park, X. Chen, T. Das, M. Kim, J. Ahn, Adv. Mater. 2016, 28, 4184. [10] K. Yang, L. Feng, X. Shi, Z. Liu, Chem. Soc. Rev. 2013, 42, 530. [11] J. Shen, Y. Zhu, X. Yang, C. Li, Chem. Commun. 2012, 48, 3686. [12] J. T. Robinson, S. M. Tabakman, Y. Liang, H. Wang,\nH. S. Casalongue, D. Vinh, H. Dai, J. Am. J. Am. Chem. Soc. 2011, 133, 6825. [13] K. Yang, L. Hu, X. Ma, S. Ye, L. Cheng, X. Shi, C. Li, Y. Li, Z. Liu, Adv. Mater. 2012, 24, 1868. [14] a) M. Chhowalla, H. S. Shin, G. Eda, L. Li, K. P. Loh, H. Zhang, Nat. Chem. 2013, 5, 263; b) Q. Wang, K. Kalantar-Zadeh, A. Kis, J. N. Coleman, M. S. Strano, Nat. Nanotechnol. 2012, 7, 699. [15] H. Lin, Y. Chen, J. Shi, Adv. Sci. 2018, 5, 1800518. [16] D. Golberg, Y. Bando, Y. Huang, T. Terao, M. Mitome, C. Tang,\nC. Zhi, ACS Nano 2010, 4, 2979. [17] P. Niu, L. Zhang, G. Liu, H. Cheng, Adv. Funct. Mater. 2012, 22,\n4763. [18] X. Liu, C. Guan, D. Wang, L. Wan, Adv. Mater. 2014, 26, 6912. [19] L. Wang, Y. Wang, J. Wong, T. Palacios, J. Kong, H. Yang, Small\n2014, 10, 1101. [20] X. Zhang, X. Xie, H. Wang, J. Zhang, B. Pan, Y. Xie, J. Am. Chem.\nSoc. 2013, 135, 18. [21] X. Zhang, H. Wang, H. Wang, Q. Zhang, J. Xie, Y. Tian, J. Wang,\nY. Xie, Adv. Mater. 2014, 26, 4438. [22] Y. Luo, Z. Li, C. Zhu, X. Cai, L. Qu, D. Du, Y. Lin, Trends Biotechnol.\n2018, 36, 1145. [23] Y. Zhang, Y. Zheng, K. Rui, H. Hng, K. Hippalgaonkar, J. Xu,\nW. Sun, J. Zhu, Q. Yan, W. Huang, Small 2017, 13, 1700661. [24] C. Hao, B. Yang, F. Wen, J. Xiang, L. Li, W. Wang, Z. Zeng, B. Xu,\nZ. Zhao, Z. Liu, Y. Tian, Adv. Mater. 2016, 28, 3194. [25] H. Liu, Y. Du, Y. Deng, P. D. Ye, Chem. Soc. Rev. 2015, 44, 2732. [26] R. Irshad, K. Tahir, B. Li, Z. Sher, J. Ali, S. Nazir, J. Ind. Eng. Chem.\n2018, 64, 60. [27] P. Bridgman, J. Am. Chem. Soc. 1914, 36, 1344. [28] a) W. Lei, G. Liu, J. Zhang, M. Liu, Chem. Soc. Rev. 2017, 46, 3492;\nb) T. H. Lee, S. Y. Kim, H. W. Jang, Nanomaterials 2016, 6, 194. [29] A. Carvalho, M. Wang, X. Zhu, A. S. Rodin, H. Su, A. H. Castro\nNeto, Nat. Rev. Mater. 2016, 1, 16061. [30] X. Yang, G. Liu, Y. Shi, W. Huang, J. Shao, X. Dong, Nanotech-\nnology 2018, 29, 222001. [31] S. Kuriakose, T. Ahmed, S. Balendhran, V. Bansal, S. Sriram,\nM. Bhaskaran, S. Walia, 2D Mater. 2018, 5, 032001. [32] Y. Abate, D. Akinwande, S. Gamage, H. Wang, M. Snure,\nN. Poudel, S. B. Cronin, Adv. Mater. 2018, 30, 1704749. [33] Z. Hu, T. Niu, R. Guo, J. Zhang, M. Lai, J. H2, L. Wang, Nanoscale\n2018, 10, 21575. [34] a) H. Wang, X. Yu, Small 2018, 14, 1702830; b) M. Qiu, W. Ren,\nT. Jeong, M. Won, G. Park, D. Sang, L. Liu, H. Zhang, J. Kim, Chem. Soc. Rev. 2018, 47, 5588. c) S. Anju, J. Ashtami, P. Mohanan, Mater. Sci. Eng., C 2019, 97, 978.\n1900318 (30 of 32) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimAdv. Funct. Mater. 2019, 29, 1900318\n[35] J. N. Coleman, M. Lotya, A. O’Neill, S. D. Bergin, P. J. King, U. Khan, K. Young, A. Gaucher, S. De, R. J. Smith, I. V. Shvets, S. K. Arora, G. Stanton, H. Kim, K. Lee, G. T. Kim, G. S. Duesberg, T. Hallam, J. J. Boland, J. Wang, J. F. Donegan, J. C. Grunlan, G. Moriarty, A. Shmeliov, R. J. Nicholls, J. M. Perkins, E. M. Grieveson, K. Theuwissen, D. W. McComb, P. D. Nellist, V. Nicolosi, Science 2011, 331, 568. [36] a) K. Novoselov, A. Geim, S. Morozov, D. Jiang, Y. Zhang, S. Dubonos, I. Grigorieva, A. Firsov, Science 2004, 306, 666; b) B. Radisavljevic, A. Radenovic, J. Brivio, V. Giacometti, A. Kis, Nat. Nanotechnol. 2011, 6, 147. [37] H. Liu, A. Neal, Z. Zhu, Z. Luo, X. Xu, D. Tománek, P. Ye, ACS Nano 2014, 8, 4033. [38] L. Guan, B. Xing, X. Niu, D. Wang, Y. Yu, S. Zhang, X. Yan, Y. Wang, J. Sha, Chem. Commun. 2018, 54, 595. [39] W. Lu, H. Nan, J. Hong, Y. Chen, C. Zhu, Z. Liang, X. Ma, Z. Ni, C. Jin, Z. Zhang, Nano Res. 2014, 7, 853. [40] A. Castellanos-Gomez, L. Vicarelli, E. Prada, J. O. Island, K. L. Narasimha-Acharya, S. I. Blanter, D. J. Groenendijk, M. Buscema, G. A. Steele, J. V. Alvarez, H. W. Zandbergen, J. J. Palacios, H. S. J. van der Zant, 2D Mater. 2014, 1, 025001. [41] Q. Li, Q. Zhou, L. Shi, Q. Chen, J. Wang, J. Mater. Chem. A 2019, 7, 4291. [42] X. Peng, Q. Wei, A. Copple, Phys. Rev. B 2014, 90, 085402. [43] J. Brent, N. Savjani, E. Lewis, S. Haigh, D. J. Lewis, P. O’Brien,\nChem. Commun. 2014, 50, 13338. [44] Z. Guo, H. Zhang, S. Lu, Z. Wang, S. Tang, J. Shao, Z. Sun, H. Xie,\nH. Wang, X. Yu, P. K. Chu, Adv. Funct. Mater. 2015, 25, 6996. [45] J. Kang, J. D. Wood, S. A. Wells, J. Lee, X. Liu, K. Chen,\nM. C. Hersam, ACS Nano 2015, 9, 3596. [46] X. Zhang, H. Xie, Z. Liu, C. Tan, Z. Luo, H. Li, J. Lin, L. Sun,\nW. Chen, Z. Xu, L. Xie, W. Huang, H. Zhang, Angew. Chem., Int. Ed. 2015, 54, 3653. [47] Z. Sun, H. Xie, S. Tang, X. Yu, Z. Guo, J. Shao, H. Zhang, H. Huang, H. Wang, P. K. Chu, Angew. Chem., Int. Ed. 2015, 54, 11526. [48] J. Xu, L. Gao, C. Hu, Z. Zhu, M. Zhao, Q. Wang, H. Zhang, Chem. Commun. 2016, 52, 8107. [49] L. Gao, J. Xu, b. Z. Zhu, C. Hu, L. Zhang, Q. Wang, H. Zhang, Nanoscale 2016, 8, 15132. [50] H. Wang, X. Yang, W. Shao, S. Chen, J. Xie, X. Zhang, J. Wang, Y. Xie, J. Am. Chem. Soc. 2015, 137, 11376. [51] M. B. Erande, S. R. Suryawanshi, M. A. More, D. J. Late, Eur. J. Inorg. Chem. 2015, 2015, 3102. [52] Z. Wang, Y. Xu, S. C. Dhanabalan, J. Sophia, C. Zhao, C. Xu, Y. Xiang, J. Li, H. Zhang, IEEE Photonics J. 2016, 8, 1503310. [53] M. Wang, Y. Liang, Y. Liu, G. Ren, Z. Zhang, S. Wu, J. Shen, Analyst 2018, 143, 5822. [54] M. B. Erande, M. S. Pawar, D. J. Late, ACS Appl. Mater. Interfaces 2016, 8, 11548. [55] Y. Xu, Z. Wang, Z. Guo, H. Huang, Q. Xiao, H. Zhang, X. F. Yu, Adv. Opt. Mater. 2016, 4, 1223. [56] Z. Sofer, D. Daniel Bouša, J. Luxa, V. Mazanek, M. Pumera, Chem. Commun. 2016, 52, 1563. [57] C. Choi, Y. Park, X. Wu, D. Kim, Chem. Eng. J. 2018, 333, 336. [58] M. Raucci, I. Fasolino, M. Caporali, M. Serrano-Ruiz, A. Soriente,\nM. Peruzzini, L. Ambrosio, ACS Appl. Mater. Interfaces 2019, 11, 9333. [59] M. Luo, T. Fan, Y. Zhou, H. Zhang, L. Mei, Adv. Funct. Mater. 2019, 29, 1808306. [60] V. Eswaraiah, Q. Zeng, Y. Long, Z. Liu, Small 2016, 12, 3480. [61] Y. Y. Illarionov, M. Waltl, G. Rzepa, J. Kim, S. Kim, A. Dodabalapur,\nD. Akinwande, T. Grasser, ACS Nano 2016, 10, 9543. [62] B. Wan, B. Yang, Y. Wang, J. Zhang, Z. Zeng, Z. Liu, W. Wang,\nNanotechnology 2015, 26, 435702.\n[63] A. Avsar, I. J. Vera-Marun, J. Tan, K. Watanabe, T. Taniguchi, A. H. Castro Neto, B. Ozyilmaz, ACS Nano 2015, 9, 4138. [64] J. Shao, H. Xie, H. Huang, Z. Li, Z. Sun, Y. Xu, Q. Xiao, X. Yu, Y. Zhao, H. Zhang, H. Wang, P. K. Chu, Nat. Commun. 2016, 7, 12967. [65] a) R. Gusmao, Z. Sofer, M. Pumera, ACS Nano 2018, 12, 5666. b) Y. Zhao, Q. Zhou, Q. Li, X. Yao, J. Wang, Adv. Mater. 2017, 29, 1603990. [66] W. Lv, B. Yang, B. Wang, W. Wan, Y. Ge, R. Yang, ACS Appl. Mater. Interfaces 2018, 10, 9663. [67] C. R. Ryder, J. D. Wood, S. A. Wells, Y. Yang, D. Jariwala, T. J. Marks, G. C. Schatz, M. C. Hersam, Nat. Chem. 2016, 8, 597. [68] I. Krossing, J. Am. Chem. Soc. 2001, 123, 4603. [69] Y. Zhao, H. Wang, H. Huang, Q. Xiao, Y. Xu, Z. n Guo, H. Xie,\nJ. Shao, Z. Sun, W. Han, X. Yu, P. Li, P. K. Chu, Angew. Chem., Int. Ed. 2016, 55, 5003. [70] G. Qu, W. Liu, Y. Zhao, J. Gao, T. Xia, J. Shi, L. Hu, W. Zhou, J. Gao, H. Wang, Q. Luo, Q. Zhou, S. Liu, X. Yu, G. Jiang, Angew. Chem., Int. Ed. 2017, 56, 14488. [71] B. Yang, B. Wan, Q. Zhou, Y. Wang, W. Hu, W. Lv, Q. Chen, Z. Zeng, F. Wen, J. Xiang, S. Yuan, J. Wang, B. Zhang, W. Wang, J. Zhang, B. Xu, Z. Zhao, Y. Tian, Z. Liu, Adv. Mater. 2016, 28, 9408. [72] Z. Guo, S. Chen, Z. Wang, Z. Yang, F. Liu, Y. Xu, J. Wang, Y. Yi, H. Zhang, L. Liao, P. K. Chu, X. Yu, Adv. Mater. 2017, 29, 1703811. [73] K. L. Kuntz, R. A. Wells, J. Hu, T. Yang, B. Dong, H. Guo, A. H. Woomer, D. L. Druffel, A. Alabanza, D. Tománek, S. C. Warren, ACS Appl. Mater. Interfaces 2017, 9, 9126. [74] R. Gui, H. Jin, Z. Wang, J. Li, Chem. Soc. Rev. 2018, 47, 6795. [75] X. Zhu, T. Zhang, D. Jiang, H. Duan, Z. Sun, M. Zhang, H. Jin,\nR. Guan, Y. Liu, M. Chen, H. Ji, P. Du, W. Yan, S. Wei, Y. Lu, S. Yang, Nat. Commun. 2018, 9, 4177. [76] S. Zhu, F. Li, G. Wang, Chem. Soc. Rev. 2013, 42, 7535. [77] S. Zhang, J. Yang, R. Xu, F. Wang, W. Li, M. Ghufran, Y.-W. Zhang,\nZ. Yu, G. Zhang, Q. Qin, Y. Lu, ACS Nano 2014, 8, 9590. [78] H. Lee, S. Park, S. Lee, S. Choi, S. Seo, H. Kim, J. Won, K. Choi,\nK. Kang, H. Park, H. Kim, H. An, K. Jeong, Y. Lee, J. Lee, Small 2016, 12, 214. [79] Y. Zhao, L. Tong, Z. Li, N. Yang, H. Fu, L. Wu, H. Cui, W. Zhou, J. Wang, H. Wang, P. K. Chu, X. Yu, Chem. Mater. 2017, 29, 7131. [80] Y. Li, Z. Liu, Y. Hou, G. Yang, X. Fei, H. Zhao, Y. Guo, C. Su, Z. Wang, H. Zhong, Z. Zhuang, Z. Guo, ACS Appl. Mater. Interfaces 2017, 9, 25098. [81] L. Deng, Y. Xu, C. Sun, B. Yun, Q. Sun, C. Zhao, Z. Li, Sci. Bull. 2018, 63, 917. [82] Z. Liu, H. Chen, Y. Jia, W. Zhang, H. Zhao, W. Fan, W. Zhang, H. Zhong, Y. Nia, Z. Guo, Nanoscale 2018, 10, 18795. [83] Z. Li, T. Guo, Y. Hu, Y. Qiu, Y. Liu, H. Wang, Y. Li, X. Chen, J. Song, H. Yang, ACS Appl. Mater. Interfaces 2019, 11, 9860. [84] C. Xing, S. Chen, M. Qiu, X. Liang, Q. Liu, Q. Zou, Z. Li, Z. Xie, D. Wang, B. Dong, L. Liu, D. Fan, H. Zhang, Adv. Healthcare Mater. 2018, 7, 1701510. [85] X. Zeng, M. Luo, G. Liu, X. Wang, W. Tao, Y. Lin, X. Ji, L. Nie, L. Mei, Adv. Sci. 2018, 5, 1800510. [86] a) L. Wang, S. Hu, Science 2012, 335, 1458; b) L. Cheng, J. Liu, X. Gu, H. Gong, X. Shi, T. Liu, C. Wang, X. Wang, G. Liu, H. Xing, W. Bu, B. Sun, Z. Liu, Adv. Mater. 2014, 26, 1886. [87] a) Y. Xia, W. Li, C. Cobley, J. Chen, X. Xia, Q. Zhang, M. Yang, E. C. Cho, P. K. Brown, Acc. Chem. Res. 2011, 44, 914; b) M. Melancon, M. Zhou, C. Li, Acc. Chem. Res. 2011, 44, 947. [88] a) Y. Lyu, J. Zeng, Y. Jiang, X. Zhen, T. Wang, S. Qiu, X. Lou, M. Gao, K. Pu, ACS Nano 2018, 12, 1801; b) Z. Cao, L. Feng, G. Zhang, J. Wang, S. Shen, D. Li, X. Yang, Biomaterials 2018, 155, 103.\n1900318 (31 of 32) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimAdv. Funct. Mater. 2019, 29, 1900318\n[89] J. Choi1, K. Yong, J. Choi, A. Nilghaz, Y. Lin, J. Xu, X. Lu, Theranostics 2018, 8, 1005. [90] Z. Sun, Y. Zhao, Z. Li, H. Cui, Y. Zhou, W. Li, W. Tao, H. Zhang, H. Wang, P. K. Chu, X. Yu, Small 2017, 13, 1602896. [91] C. Sun, L. Wen, J. Zeng, Y. Wang, Q. Sun, L. Deng, C. Zhao, Z. Li, Biomaterials 2016, 91, 81. [92] Y. Chen, L. Wang, J. Shi, Nano Today 2016, 11, 292. [93] W. Tao, X. Ji, X. Xu, M. Islam, Z. Li, S. Chen, P. Saw, H. Zhang,\nZ. Bharwani, Z. VGuo, J. Shi, O. Farokhzad, Angew. Chem., Int. Ed. 2017, 56, 11896. [94] X. Yang, D. Wang, J. Zhu, L. Xue, C. Ou, W. Wang, M. Lu, X. Song, X. Dong, Chem. Sci. 2019, 10, 3779. [95] X. Qian, Z. Gu, Y. Chen, Mater. Horiz. 2017, 4, 800. [96] J. Liu, T. Liu, P. Du, L. Zhang, J. Lei, Angew. Chem., Int. Ed. 2019,\nhttps://doi.org/10.1002/anie.201903475. [97] X. Yang, D. Wang, Y. Shi, J. Zou, Q. Zhao, Q. Zhang, W. Huang,\nJ. Shao, X. Xie, X. Dong, ACS Appl. Mater. Interfaces 2018, 10, 12431. [98] C. Xing, G. Jing, X. Liang, M. Qiu, Z. Li, R. Cao, X. Li, D. Fan, H. Zhang, Nanoscale 2017, 9, 8096.\n[99] Y. Yi, X. Yu, W. Zhou, J. Wang, P. Chu, Mater. Sci. Eng., R 2017, 120, 1. [100] J. Miao, B. Song, Q. Li, L. Cai, S. Zhang, W. Hu, L. Dong, C. Wang,\nACS Nano 2017, 11, 6048. [101] H. Fu, Z. Li, H. Xie, Z. Sun, B. Wang, H. Huang, G. Han, H. Wang,\nP. K. Chuc, X. Yu, RSC Adv. 2017, 7, 14618. [102] T. Guo, Y. Lin, G. Jin, R. Weng, J. Song, X. Liu, G. Huang, L. Hou,\nH. Yang, Chem. Commun. 2019, 55, 850. [103] J. Liu, P. Du, T. Liu, B. J. Córdova Wong, W. Wang, H. Ju, J. Lei,\nBiomaterials 2019, 192, 179. [104] J. Liu, P. Du, H. Mao, L. Zhang, H. Ju, J. Lei, Biomaterials 2018,\n172, 83. [105] R. Lv, D. Yang, P. Yang, J. Xu, F. He, S. Gai, C. Li, Y. Dai, G. Yang,\nJ. Lin. Chem. Mater. 2016, 28, 4724. [106] T. Guo, Y. Wu, Y. Lin, X. Xu, H. Lian, G. Huang, J. Liu, X. Wu,\nH. Yang, Small 2018, 14, 1702815. [107] a) X. Ji, N. Kong, J. Wang, W. Li, Y. Xiao, S. Gan, Y. Zhang, Y. Li,\nX. Song, Q. Xiong, S. Shi, Z. Li, W. Tao, H. Zhang, L. Mei, J. Shi, Adv. Mater. 2018, 30, 1803031; b) S. Geng, L. Wu, H. Cui, W. Tan, T. Chen, P. Chu, X. Yu, Chem. Commun. 2018, 54, 6060. [108] W. Tao, X. Zhu, X. Yu, X. Zeng, Q. Xiao, X. Zhang, X. Ji, X. Wang, J. Shi, H. Zhang, L. Mei, Adv. Mater. 2017, 29, 1603276. [109] S. Zong, L. Wang, Z. Yang, H. Wang, Z. Wang, Y. Cui, ACS Appl. Mater. Interfaces 2019, 11, 5896. [110] G. Yang, X. Wan, Z. Gu, X. Zeng, J. Tang, J. Mater. Chem. B 2018, 6, 1622. [111] M. Qiu, D. Wang, W. Liang, L. Liu, Y. Zhang, X. Chen, D. K. Sang, C. Xing, Z. Li, B. Dong, F. Xing, D. Fan, S. Bao, H. Zhang, Y. Cao. Proc. Natl. Acad. Sci. USA 2018, 115, 501. [112] B. Yang, J. Yin, Y. Chen, S. Pan, H. Yao, Y. Gao, J. Shi, Adv. Mater. 2018, 30, 1705611. [113] X. Wang, J. Shao, M. Raouf, H. Xie, H. Huang, H. Wang, P. K. Chu, X. Yu, Y. Yang, A. AbdEl-Aal, N. Mekkawy, R. Miron, Y. Zhang, Biomaterials 2018, 179, 164. [114] L. Tong, Q. Liao, Y. Zhao, H. Huang, A. Gao, W. Zhang, X. Gao, W. Wei, M. Guan, P. K. Chu, H. Wang, Biomaterials 2019, 193, 1. [115] W. Chen, J. Ouyang, X. Yi, Y. Xu, C. Niu, W. Zhang, L. Wang, J. Sheng, L. Deng, Y. Liu, S. Guo, Adv. Mater. 2018, 30, 1703458. [116] D. Yang, G. Yang, P. Yang, R. Lv, S. Gai, C. Li, F. He, J. Lin, Adv. Funct. Mater. 2017, 27, 1700371. [117] W. Chen, J. Ouyang, H. Liu, M. Chen, K. Zeng, J. Sheng, Z. Liu, Y. Han, L. Wang, J. Li, L. Deng, Y. Liu, S. Guo, Adv. Mater. 2017, 29, 1603864. [118] a) H. Yin, R. Kanasty, A. Eltoukhy, A. Vegas, J. Dorkin, D. Anderson, Nat. Rev. Genet. 2014, 15, 541; b) D. Bumcrot, M. Manoharan, V. Koteliansky, D. Sah, Nat. Chem. Biol. 2006, 2, 711.\n[119] a) J. Shen, W. Zhang, R. Qi, Z. Mao, H. Shen, Chem. Soc. Rev. 2018, 47, 1969; b) B. Nordestgaard, S. Nicholls, A. Langsted, K. Ray, A. Tybjoerg-Hansen, Nat. Rev. Cardiol. 2018, 15, 261. [120] L. Chen, C. Chen, W. Chen, K. Li, X. Chen, X. Tang, G. Xie, X. Luo, X. Wang, H. Liang, S. Yu, ACS Appl. Mater. Interfaces 2018, 10, 21137. [121] H. Wang, L. Zhong, Y. Liu, X. Xu, C. Xing, M. Wang, S. Bai, C. Lu, H. Yang, Chem. Commun. 2018, 54, 3142. [122] a) Q. Chen, L. Xu, C. Liang, C. Wang, R. Peng, Z. Liu, Nat. Commun. 2016, 7, 13193; b) L. Luo, R. Shu, A. Wu, J. Mater. Chem. B 2017, 5, 5517. [123] S. Toraya-Brown, M. Sheen, P. Zhang, L. Chen, J. Baird, E. Demidenko, M. Turk, P. Jack Hoopes, DVM, J. Conejo-Garcia, S. Fiering, Nanomedicine 2014, 10, 1273. [124] W. Ou, J. H. Byeon, R. Thapa, S. K. Ku, C. S. Yong, J. Kim, ACS Nano 2018, 12, 10061. [125] X. Liang, X. Ye, C. Wang, C. Xing, Q. Miao, Z. Xie, X. Chen, X. Zhang, H. Zhang, L. Mei, J. Controlled Release 2019, 296, 150. [126] a) Y. Du, S. Dong, Anal. Chem. 2017, 89, 189; b) Y. Wang, K. Huang, X. Wu, Biosens. Bioelectron. 2017, 97, 305; c) S. Kurbanoglu, S. Ozkan, A. Merkoci, Biosens. Bioelectron. 2017, 89, 886. [127] Y. Song, Y. Luo, C. Zhu, H. Li, D. Du, Y. Lin, Biosens. Bioelectron. 2016, 76, 195. [128] S. Kumar, Y. Lei, N. Alshareef, M. Quevedo-Lopez, K. Salama, Biosens. Bioelectron. 2018, 121, 243. [129] Y. Zhao, Y. Zhang, Z. Zhuge, Y. Tang, J. Tao, Y. Chen, Anal. Chem. 2018, 90, 3149. [130] V. Kumar, J. R. Brent, M. Shorie, H. Kaur, G. Chadha, A. G. Thomas, E. A. Lewis, A. P. Rooney, L. Nguyen, X. i Zhong, M. G. Burke, S. J. Haigh, A. Walton, P. D. McNaughter, A. A. Tedstone, N. Savjani, C. A. Muryn, P. O’Brien, A. K. Ganguli, D. J. Lewis, P. Sabherwal, ACS Appl. Mater. Interfaces 2016, 8, 22860. [131] S. K. Tuteja, S. Neethirajan, Nanotechnology 2018, 29, 135101. [132] X. Li, X. Niu, W. Zhao, W. Chen, C. Yin, Y. Men, G. Li, W. Sun,\nElectrochem. Commun. 2018, 86, 68. [133] C. C. Mayorga-Martinez, N. Mohamad Latiff, A. Y. Sheng Eng,\nZ. Sofer, M. Pumera, Anal. Chem. 2016, 88, 10074. [134] S. Yan, B. Wang, Z. Wang, D. Hu, X. Xu, J. Wang, Y. Shi, Biosens.\nBioelectron. 2016, 80, 34. [135] a) K. Maehashi, T. Katsura, K. Kerman, Y. Takamura, K. Matsumoto,\nE. Tamiya, Anal. Chem. 2007, 79, 782; b) B. Chakraborty, S. Ghosh, N. Das, C. RoyChaudhuri, Biosens. Bioelectron. 2018, 122, 58. [136] S. Mao, J. Chang, H. Pu, G. Lu, Q. He, H. Zhang, J. Chen, Chem. Soc. Rev. 2017, 46, 6872. [137] I. Gablech, J. Pekarek, J. Klempa, V. Svatos, A. Sajedi-Moghaddam, P. Neuzil, M. Pumera, TrAC, Trends Anal. Chem. 2018, 105, 251. [138] Y. Chen, R. Ren, H. Pu, J. Chang, S. Mao, J. Chen, Biosens. Bioelectron. 2017, 89, 505. [139] a) S. Jung, X. Chen, Adv. Healthcare Mater. 2018, 7, 1800252; b) C. Jiang, B. Liu, M. Han, Z. Zhang, Small Methods 2018, 2, 1700379; c) N. Razmia, M. Hasanzadeh, TrAC, Trends Anal. Chem. 2018, 108, 1. [140] a) Y. Jeonga, Y. Kookb, K. Leea, W. Koh, Biosens. Bioelectron. 2018, 111, 102; b) R. Huang, N. He, Z. Li, Biosens. Bioelectron. 2018, 109, 27. [141] W. Gu, X. Pei, Y. Cheng, C. Zhang, J. Zhang, Y. Yan, C. Ding, Y. Xian, ACS Sens. 2017, 2, 576. [142] W. Gu, Y. Yan, X. Pei, C. Zhang, C. Ding, Y. Xian, Sens. Actuators, B 2017, 250, 601. [143] Y. T. Yew, Z. Sofer, C. C. Mayorga-Martineza, M. Pumera, Mater. Chem. Front. 2017, 1, 1130. [144] J. Zhou, Z. Li, M. Ying, M. Liu, X. Wang, X. Wang, L. Cao, H. Zhang, G. Xu, Nanoscale 2018, 10, 5060. [145] Z. Hua, Y. Lia, E. Hussaina, X. Huang, Y. Zhang, N. Niu, S. A. Shahzade, C. Yu, Talanta 2019, 197, 270.\n1900318 (32 of 32) © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, WeinheimAdv. Funct. Mater. 2019, 29, 1900318\n[146] H. Liu, M. Sun, Y. Su, D. Deng, J. Hua, Y. Lv, Chem. Commun. 2018, 54, 7987. [147] a) K. Fujiwara, Anal. Chem. 1989, 61, 2699; b) M. R. K. F. Kazuko, K. Fuwa, Anal. Chem. 1983, 55, 1665. [148] a) L. Li, Y. Chen, J. Zhu, Anal. Chem. 2017, 89, 358; b) W. Miao, Chem. Rev. 2008, 108, 2506; c) A. Chen, S. Ma, Y. Zhuo, Y. Chai, R. Yuan, Anal. Chem. 2016, 88, 3203. [149] a) W. Miao, J. Choi, A. Bard, J. Am. Chem. Soc. 2002, 124, 14478; b) Y. Dong, Y. Zhou, J. Wang, J. Zhu, Anal. Chem. 2016, 88, 5469. [150] a) Z. Ding, B. Quinn, S. Haram, L. Pell, B. Korgel, A. Bard, Science 2002, 296, 1293; b) J. Yu, Y. Rong, C. Kuo, X. Zhou, D. Chiu, Anal. Chem. 2017, 89, 42. [151] L. Zhang, K. Tian, Y. Dong, H. Ding, C. Wang, Analyst 2018, 143, 304. [152] H. Ding, Z. Tang, L. Zhang, Y. Dong, Analyst 2019, 144, 1326. [153] a) X. Wang, N. Choi, Z. Cheng, J. Ko, L. Chen, J. Choo, Anal. Chem. 2017, 89, 1163; b) J. Liu, Y. Lu, J. Am. Chem. Soc. 2003, 125, 6642; c) S. Ahmed, M. Bui, A. Abbas, Biosens. Bioelectron. 2016, 77, 249. [154] a) N. Nath, C. Ashutosh, Anal. Chem. 2002, 74, 504; b) Y. Jiang, M. Shi, Y. Liu, S. Wan, C. Cui, L. Zhang, W. Tan, Angew. Chem., Int. Ed. 2017, 56, 11916. [155] J. Peng, Y. Lai, Y. Chen, J. Xu, L. Sun, J. Weng, Small 2017, 13, 1603589."
    } ],
    "references" : [ {
      "title" : "Chem",
      "author" : [ "P. Bridgman", "J. Am" ],
      "venue" : "Soc. 1914, 36,",
      "citeRegEx" : "27",
      "shortCiteRegEx" : null,
      "year" : 1344
    }, {
      "title" : "Chem",
      "author" : [ "G. Yang", "X. Wan", "Z. Gu", "X. Zeng", "J. Tang", "J. Mater" ],
      "venue" : "B 2018, 6,",
      "citeRegEx" : "110",
      "shortCiteRegEx" : null,
      "year" : 1622
    } ],
    "referenceMentions" : [ {
      "referenceID" : 0,
      "context" : "Bridgman first synthesized bulk BP through high-temperature and high-pressure transformation of white phosphorus in 1914,[27] but the related fundamental research and application did not achieve the considerable breakthrough until the discovery of layered BP in 2014.",
      "startOffset" : 121,
      "endOffset" : 125
    }, {
      "referenceID" : 1,
      "context" : "Besides BP nanosheets as the nanocarrier, NIR photothermal effect of BP nanosheets timely contributed to the controlled release of drug.[97,110] The thermal-responsive BP@hydrogel nanostructures with DOX encapsulated inside displayed improved cancer therapy.",
      "startOffset" : 136,
      "endOffset" : 144
    } ],
    "year" : 2019,
    "abstractText" : "© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim 1900318 (1 of 32) Black phosphorus nanostructures (nano-BPs) include BP nanosheets, BP quantum dots, and BP nanoparticles. Since first being discovered in 2014, nano-BP has become one of the most popular nanomaterials. Nano-BP has many unique properties, such as excellent surface activity, tunable bandgap, high carrier mobility, moderate on/off ratio, excellent biocompatibility, good biodegradation, etc., all of which make nano-BP particularly attractive in biomedicine and biosensing. This review article comprehensively summarizes recent advances in synthesis, functionalization, biomedicine, and biosensing applications of nano-BP. Different methods are first introduced, such as mechanical cleavage, liquid-phase ultrasonic exfoliation, electrochemical exfoliation, solvothermal treatment, and acoustic-microfluidic stripping, for making the nano-BP. Then two strategies are emphasized to enhance ambient stability of nano-BP, namely physical encapsulation and chemical modification. Next, how to develop nano-BP as advanced imaging agents, nanocarriers, and nanomedicine for bioimaging (fluorescence imaging, thermal imaging, and photoacoustic imaging) and disease treatment (phototherapy and photo/chemical/immune synergistic therapy) is demonstrated. The biosensing applications on nano-BP is introduced, including electrochemical biosensor, fluorescence biosensor, chemiluminescence biosensor, electrogenerated chemiluminescence biosensor, and colorimetric biosensor. Finally, the current challenges and future perspectives on nano-BP in bioapplications are discussed. Recent Advances on Black Phosphorus for Biomedicine and Biosensing",
    "creator" : "Adobe InDesign CS6 (Macintosh)"
  }
}